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  General introduction: Peripartum of dairy cows 
PERIPARTUM OF DAIRY COWS 
During the last decades genetic selection allowed a huge increase in milk 
production of dairy cows in a short period of time, especially for the widespread and 
most productive Holstein breed. It is reported that such a genetic improvement 
came only partially with a consistent and quick adaptation of all the other factors 
involved in dairy cows rearing. The “new” high-production dairy cow has to face 
new issues, unknown to the “old” animals. Feeding and management have to be 
carefully taken into account to provide a good response to requirements raised by 
genetic improvements. Research provided in the course of time new techniques to 
cover the increased requirements, and new structures were framed to better house 
and take care of animals. The adaptation of the cow to the higher requirements may 
be rather simple in some life stages characterized by a not so high production and 
by a constant metabolism (e.g. established lactation). However, around calving the 
cow is facing a challenge due to sudden and strong modifications in her metabolism 
and life in general. This is the so-called transition period of dairy cow (or peripartum), 
defined by Grummer (1995) as the period of time from 3 weeks before calving 
through the first 3 weeks after calving. Most of the troubles which may occur in the 
cow’s life usually concentrates in this short period (Trevisi, 2010). However, this is 
not only a temporary problem, but it may also negatively affect the whole following 
lactation causing an increased risk of diseases, a lower milk yield and resulting in an 
increase of costs. For these reasons it is important to focus the efforts on this 
physiological stage to find suitable solution to reduce the count of occurring 
problems and their severity. Feeding management has major importance in this 
challenge, since an unbalanced diet may worsen ongoing problems or rise new. 
Furthermore, it is clear that an incorrect feeding management during peripartum 
may negatively affect the negative energy balance, resulting in a worsening of the 
reproductive performances (Bertoni et al., 2009; Butler et al., 1981; Wathes et al., 
2007) and consequently adding costs for farmers. 
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It is not an easy task to find the causes of the problems occurring in the 
peripartum period since it is well known that many of them have a multi-factor 
etiology. One of these may be an insufficient response to stress. In this phase there 
are several possible stress sources for the cow, such as the calving itself, group 
changing, not proper availability of feed or water, not suitable housing. The 
prevention of any stress is an essential prerequisite to the animal welfare in general, 
but in particular in this phase (Calamari, 2003). It is important to point up that the 
consequences to stress factors not always are clinical illnesses, but many times they 
take subclinical forms implying subtle consequences that anyhow may cause losses 
in cow’s health and/or milk yield. An important stress is due to the physiological 
changings occurring in the organism during dry period. After dry off, cow enters in 
a phase characterized by no requirements for milk production but with an increasing 
importance of the foetus. In late pregnancy its size can be great enough to influence 
cow’s metabolism, in particular for energy requirements. Calving itself implies a 
number of endocrine variations, often coming with other changes in cow’s life (e.g. 
group and diet change, different housing). Later, with the onset of lactation, 
requirements (especially energy and protein) dramatically increase, forcing the cow 
to draw energy from body reserves (Drackley, 1999; Overton, 2001). The 
mechanisms that control the physiological status switch from homeostasis to 
homeoresis (Bauman, 2000), implying a number of important endocrine variations 
(mainly involving GH and insulin) that make more nutrients available in the 
mammary gland than in other tissues. 
MAIN METABOLIC AND RELATED EVENTS OCCURRING IN 
TRANSITION PERIOD OF DAIRY COWS 
1. Inadequate feed intake at the end of pregnancy and onset of lactation. During 
the dry period energy and protein requirements lower, as there are no needs by 
the udder for milk production. In this condition, as in late lactation, the cow is 
able to gather some energy reserves in adipose tissues. However, also the daily 
intake is lower than in lactation, causing a small reduction in the size of rumen, 
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and particularly in papillae number and size (Goff and Horst, 1997). 
Approaching calving the DMI undergoes a further reduction caused by several 
possible factors mainly linked to physiological changes far to be clarified. This 
allows the possibility that a negative energy balance may occur already before 
calving. For instance, the reduction of feed intake at the end of pregnancy may 
be explained by the presence of clinical or subclinical diseases (Trevisi et al., 
2002). Immediately after calving requirements dramatically increase, and the cow 
attempts to match it with reserves mobilization and by increasing the feed 
intake. However the small size of rumen doesn’t allow the intake of large 
amounts of feed and the reduced number/size of papillae cannot quickly soak 
up the increased amount of volatile fatty acids (Goff and Horst, 1997). 
Furthermore, glucose undergoes a major requirement immediately after calving 
mainly due to the production of lactose in the mammary gland. The tremendous 
gap between glucose requirement and glucose availability in early lactating cows 
was estimated by Drackley et al. (2001) as 500 g/d. The organism tries to fill the 
gap by increasing the gluconeogenesis, using as substrate mainly amino acids and 
glycerol from body reserves. This is a different condition in respect to the cow 
afar from calving with a correct feed intake, when the main energy contributor is 
the propionate from rumen and glycerol is limited to a marginal amount. 
Further factors affecting the lowering of DMI in the peripartum are clinical or 
subclinical health problems.. The mechanism that exerts this effect is partly due 
to the release of cytokines characterized by anorectic effect (e.g. Tumor Necrosis 
Factor-α, Interleukin-1, Interleukin-6) which occurs during the inflammatory 
response. There is just a few bibliography dealing with cytokines in dairy cows: a 
recent paper from (Trevisi et al., 2011) describes the IL-6 response to metabolic 
stress in periparturient dairy cows. However, the action of some cytokines in 
lowering appetite and consequently the feed intake is a well-known mechanism 
(Grimble, 1990; Johnson, 1998; Kelley et al., 2003). The consequence of a not 
adequate feed intake is a marked mobilization of body reserves and so likely the 
impossibility to achieve the maximum productive potential. 
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2. Mobilization of body fat reserves to support lactation. This phenomenon is 
due to the marked energy deficit in postpartum and it is promoted by the growth 
hormone (GH) plasma level increase and insulin decrease. The mobilized non-
esterified fatty acids (NEFA) may be used by peripheral tissues, in particular they 
are processed in liver where they can be esterified in triacylglycerols and excreted 
in blood within very low density lipoprotein (VLDL). NEFA are usually 
oxidized in mitochondria to get energy, but Drackley (2001) argues that an 
alternative pathway, in peroxisomes, is activated when NEFA are present in 
large amount. When the apolipoproteins production is impaired in the liver, the 
triglycerides (TG) excretion is reduced, thus they are gathered in the hepatocytes, 
causing liver steatosis (Drackley, 1999). This pathology has important 
implications on the liver functionality and on the overall health status. In order 
to meet the increased mobilization requirement after calving, a proper body 
condition score is desirable. Indeed, several authors report that an excessively 
fatty cow may be more easily affected by problems at calving time or later 
(Bernabucci et al., 2005; Pryce et al., 2001; Reid et al., 1986). 
3. Oxidative stress. According to Sies (1997), an imbalance between oxidants and 
antioxidants in favour of the oxidants, potentially leading to damage, is termed 
“oxidative stress”. A number of studies shows as a variety of reactive oxygen 
species (ROS) are produced by normal metabolic processes and by certain 
leukocyte populations during defense against disease. However, less is known 
about how oxidative stress can affect health status and well-being, particularly 
during times of high metabolic activity. In these conditions the considerable 
increase in oxygen requirements results in a raise of ROS production. In the 
periparturient dairy cow an imbalance between increased production of ROS 
and the availability of antioxidant defenses needed to reduce ROS accumulation 
may expose cows to increased oxidative stress. Early studies suggested a role of 
oxidative stress in the etiologies of dairy cattle disorders since supplementation 
with certain antioxidants could ameliorate the severity of a variety of metabolic 
and infectious diseases (Miller et al., 1993). There are now several recent studies 
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to support the concept that oxidative stress is an important factor in the 
enhancement of the immune and inflammatory responses through an increased 
susceptibility of dairy cattle to a variety of health disorders, particularly during 
the transition period (Allison and Laven, 2000; Bernabucci et al., 2005; Castillo et 
al., 2005; Sordillo, 2005; Wilde, 2006). 
4. Immunosuppression status. The immune response is the organism’s reaction 
to the presence and multiplication of pathogens or to antigenic substances. Two 
kinds of response are observed: innate and acquired. The first one is composed 
by a number of non-specific defense mechanisms, such as physic-chemical walls 
(e.g. skin), phagocytic cells (e.g. macrophages, neutrophils), plasma proteins (e.g. 
complement and mediators of inflammation), soluble factors (substances 
exerting actions on other cells, e.g. some cytokines). Innate response is 
characterized by a quick action (between 0 and 96 hours from stimulus), high 
efficiency without giving any immunologic memory. The acquired response 
takes a specific action against different stimuli. Pathogens are recognized and 
specific cells (e.g. T lymphocytes) are recruited in order to fight them. First 
response time is delayed with respect to the innate response than the innate 
system, but once a pathogen is recognized, the immune memory is acquired and 
can also be everlasting. Several works report as immune system is partly 
impaired during the peripartum of dairy cow. Goff et al. (1997) argue that 
changes in plasma hormones levels (mainly progesterone) may alter the function 
of leukocytes. Such an effect take an action just the day before and after calving, 
when progesterone is markedly reduced. Conversely, Kehrli and collaborators 
(Kehrli et al., 1989; Kehrli et al., 1989; Kehrli et al., 1999) stated that the decrease 
in immune function would begin already before calving and lasting through 2-3 
weeks after it, and showed the reduction in the activity of neutrophils and 
macrophage. This loss of function may derive by the gene expression reduction 
of about 30 genes (Burton et al., 2001) partly due to the increase in steroidal 
hormones and partly to stress phenomena. Stabel et al. (2003) describe the 
possibility of a connection with other factors (e.g. feeding, negative energy 
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balance) and point up that the reduced immunity negatively affects the cow’s 
capability to resist to new infections often occurring in this period. 
5. Inflammation. It is generally assumed that the decreased efficiency of the 
immune system in late pregnancy is one of the major causes that make cows 
more susceptible to infections and perhaps metabolic diseases in this stage 
(Drackley et al., 2001; Goff, 2006). However, an inflammatory status – a specific 
defense mechanism associated to the innate immune system - often occurs in 
periparturient cows even without any clinical symptom (Bertoni et al., 2008; 
Cappa et al., 1989; Petersen et al., 2004; Sordillo et al., 2009). Several factors may 
contribute to trigger the inflammatory response around calving in a clinical or 
subclinical form: infectious or metabolic diseases, parasites, trauma, endotoxins 
from the gut. The common factor of these causes is likely represented by the 
pro-inflammatory cytokines release (Grimble, 1990), whose main effects concern 
liver synthesis, nutrient partitioning, anorexia, and reproductive activity through 
the triggering of the acute phase response (Moshage, 1997). The amount and the 
release time of cytokines are the main factors affecting the severity of the 
triggered effects. One of the major of them is the stimulation of the acute phase 
response (Elsasser et al., 2000; Fleck, 1989), which in liver is characterized by the 
increased production of some proteins (positive acute phase proteins, +APP) 
and the impairment in the production of some other proteins (negative acute 
phase proteins, -APP). The determination in plasma of +APP (e. g. haptoglobin, 
ceruloplasmin) may be very helpful to detect the presence of an inflammatory 
status, also in case of a subclinical form. The assessment of –APP (e. g. 
albumins, retinol binding protein, apolipoproteins) can give some information 
on the response of the organism to the ongoing inflammation. 
Pro-inflammatory cytokines exert an important effect in the nutrients 
channeling, e.g. promotion of heat production (fever) and worsening the 
anorexic status of cows at calving (Johnson et al., 2001; Kelley et al., 2003). The 
combination of all these effects comes out in a worsening of the (likely already 
negative) energy balance (Pryce et al., 2001; Trevisi et al., 2009) and in the 
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increased risk of liver lipidosis (Bertoni et al., 2006; Katoh, 2002), which may also 
be causes of reduced reproductive efficiency (Bertoni et al., 2008; Butler, 2000). 
All these metabolic events may have a role in worsening existing problems in the 
animal’s health. A situation of clinical or subclinical illness is characterized by the 
release of pro-inflammatory cytokines (IL-1, IL-6, TNFα; Feghali et al., 1997), 
protein mediators causing anorexia and consequently a lower availability of nutrients 
for the mammary gland, together with higher requirements due to the need of 
tissues to counteract the illness. In this condition of “metabolic stress” the energy 
provided by reserves and intake often is not sufficient to cover all the metabolic 
expenses, resulting in a lower milk production and in a weaker ability to counteract 
illnesses. A so critical framework describes as it is as crucial as difficult to avoid any 
problem during the peripartum, which may also negatively affect the whole lactation 
and even the cow’s career. 
DISEASES AND HEALTH DISORDERS IN PERIPARTURIENT DAIRY 
COWS 
The occurrence of health problems (mainly caused by inadequate feeding, 
infections and trauma) increases in the peripartum period of dairy cows, favored by 
the sudden and major endocrine and metabolic changings taking place in the cow’s 
organism in this phase. This condition needs special cares, but a late intervention is 
not the only reason which can worsen the situation. At this moment, an intervention 
is almost impossible for those cows which do not show any evident problem, but 
may suffer a subclinical disease status. 
Liver is a major organ in processing energy for the body. Fat reserves are 
mobilized as NEFA whenever energy requirements are increased. Plasma NEFA are 
mainly uptaken by liver (Reynolds et al., 2003), where they are oxidized or esterified 
in triglycerides and consequently excreted in the blood flow within lipoproteins. An 
insufficient lipoprotein release on the first day of lactation cause the possible onset 
of severe (triglycerides > 20 % of liver dry matter) or mild lipidosis (triglycerides 
between 10 and 20 %) in 50-60% of cows (Grummer, 1993). However, the liver is 
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also an important organ in protein production, either in normal conditions and after 
inflammatory events that trigger the acute phase response. If the presence of 
inflammation is added to the normal conditions, it is known that the liver undergoes 
an extra effort in the attempt to satisfy all the needs resulting in an increase in the 
release of some proteins involved in the acute phase response (positive acute phase 
proteins, +APP) and in the decreased release of some proteins synthesized in 
normal conditions (negative acute phase proteins, -APP; Gruys et al., 2005). 
In dairy cow, liver functionality is not usually impaired during the dry period and, 
accordingly, the usual protein systems are not altered. On the contrary, after calving, 
the risk of ketosis and/or liver steatosis increases. Indeed, Herdt (1988) reports as a 
steatosis condition may arise in a few hours already immediately before calving; this 
is certainly caused by the liver functionality impairment and it is often connected to 
a lower DMI and to an important plasma NEFA increase after lipomobilization 
(Grummer, 1993). Furthermore, the partial inability of the target tissues to 
completely oxidize NEFA contributes to prevent the drop of their plasma level. 
Most of NEFA have to be esterified in triglycerides and excreted in the blood 
within lipoproteins, but it has been reported the reduced ability of periparturient 
cows to produce apolipoproteins (Bertoni et al., 1983; 1984; Calamari et al., 1989) 
and consequently to excrete fats from liver, resulting in an increased risk of 
steatosis. Drackley et al. (1999; 2001) stated as a major importance in this process is 
due to the liver impairment to oxidize NEFA in peroxisomes. A decrease in the 
production of apolipoproteins is usual in bovines, but Reid et al. (1986) interestingly 
argue that such a decrease comes with an higher frequency of diseases and a plasma 
increase of +APP (Bertoni et al., 2006; Bradford et al., 2009). Thus, it is probable the 
connection between diseases, cytokines release, acute phase response and deviation 
of protein synthesis in liver. 
Among the tremendous changes in the cow metabolism at calving, the onset of 
lactation causes a massive and quick increase in Ca requirement (Horst et al., 1997), 
occurring when DMI is depressed. If the mobilization from bones is not sufficient 
as well, the cow may be affected by milk fever, an impairment of muscular motility 
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due to lack of Ca necessary for the normal muscular motility. The onset of such a 
problem may be harmful for the animal if not quickly solved, even if it arises in a 
subclinical form. 
Furthermore, in early lactation, the cow is usually subjected to a sudden change in 
diet composition: the need to cover requirements for milk production makes the 
diet richer in more fermentable starch. Moreover, the rumen decreased, during the 
dry period, part of its capability to absorb volatile fatty acids (VFA). The increased 
production of VFA and their decreased absorption cause their accumulation in 
rumen with a consequent mild lowering of pH (ruminal acidosis). After this, rumen 
microbial profile changes and the new predominant microorganisms cause an 
increase in the production of lactic acid, causing a further pH drop. The critical pH 
threshold for acute acidosis is usually assumed to be <5.0, while for sub-acute 
acidosis is <5.5 (Nocek, 1997). As a consequence of the altered bacterial flora, 
endotoxins can be released and in some conditions moved into the blood. Their 
accumulation in some target tissues may cause further problems and/or clinical 
diseases, i.e. in the hoof, where the effects triggered by the accumulation of 
endotoxins may determine areas of tissue necrosis, and consequently lamenesses 
(Nocek, 1997). However, in most of cases the acidosis is subclinical, but it may in 
any case determine some important consequences on the cow’s health, such as lack 
of appetite. 
Ruminal acidosis may be a contributory cause in the development of a severe 
post-calving pathology, the displacement of abomasum (DA). Other risk factors 
that may contribute to manifest this pathology are ketosis, retained placenta, metritis 
and hypocalcaemia. DA shows when the abomasum, outstretched for the high 
content in gas and/or liquid, changes its place first from its normal position on the 
right ventral part of the abdomen to the left or right side (LDA, RDA). 
Consequences are the total stop of the passage rate of feed and of digestion, no milk 
production, lack of appetite, general suffering of the animal. Abomasum 
displacements cause economic loss in dairy herds through treatment costs (surgery), 
premature culling, lost production, and death. Current treatment costs range from 
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$100 to $200 per case, and 10% of the cows that are diagnosed with displaced 
abomasum are culled or die before the next test day. Treated cows that remain in 
the herd produce 350 kg less milk the following month than cows without a 
displaced abomasum (Shaver, 1997). 
Moreover, major health problems can derive after calving from the reproductive 
system, which is not always able to go back to a normal condition without facing 
any issue. Immediately after calving, cow may suffer an abnormal retention of foetal 
membranes beyond 24h after calving (retained placenta, RP), whose causes are 
multi-factorial and still partly unknown. Literature reports as possible factors the 
alterations in plasma levels of hormones or lipid mediators and the oxidative stress 
(Kankofer, 2002). An important role seems to be played by prostaglandins (Leidl et 
al., 1980), a family of lipid mediators involved in several biochemical pathways, 
included uterus motility and ovarian function. RP may be a contributory cause of 
other diseases of reproductive system, such as metritis and endometritis. These kind 
of inflammation of the uterus lining is in most of cases due to a bacterial infection 
and may be cause of important losses in milk yield and may also negatively affect the 
fertility of the cow (LeBlanc, 2008). The overall costs of post-calving reproductive 
diseases were reviewed by Bellows et al. (2002), who calculated an average cost of $ 
52.6 per cow per year. 
EFFECTS OF TREATMENTS TO AMELIORATE THE RESPONSE TO 
INFLAMMATION 
The inflammatory status occurring in peripartum period is cause of several 
negative consequences. Many attempts have been done to reduce them, in particular 
through treatments with cyclooxygenase antagonists. In an experiment (Bertoni et 
al., 2004), the administration of acetylsalicylic acid during the first 5 days of lactation 
lowered the main plasma inflammatory indices (haptoglobin and ceruloplasmin) and 
maintained the synthesis of usual liver proteins (albumin, lipoprotein and retinol-
binding protein), suggesting a better liver functionality. In addition, milk yield and 
reproductive performance were significantly improved. These results underline the 
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marked negative effects due to inflammation occurred around calving (likely due to 
the release of pro-inflammatory cytokines around calving) even in clinically healthy 
cows, and confirm that the inhibition of some cytokine effects (i.e. eicosanoid 
production) could be an efficient approach to improve the health status of dairy 
cattle at calving time. Good results were obtained using a more selective anti 
cyclooxygenase-2 (meloxicam; Trevisi et al., 2003) concerning body condition score 
(BCS) and fertility, but some adverse effects were highlighted on milk yield and in 
the diseases incidence (e. g. metritis). 
Another attempt was carried out administering the interferon-α (IFN-α) Trevisi et 
al. (2009) to periparturient cows (10 IU/kg of BW daily during the last two weeks of 
pregnancy or 0.5 IU/kg of BW daily until 5 DIM), but the inflammatory status 
worsened. This result is in contrast with previous works on monogastric (Amadori, 
2007; Begni et al., 2005), thus authors argued as this effect might be due to the 
prolonged contact of the administered cytokine with the oral lymphoid tissue during 
chewing that determined the unwanted increase of the cytokines effects and thus a 
shift of the physiological effect to pro-inflammatory condition. Moreover, during 
this experiment, an increase in pro-inflammatory cytokines was found before calving 
not only in treated cows, but also in controls, providing a further evidence that a 
systemic inflammatory status exists in transition cows. 
Alternative way to reduce the release of pro-inflammatory cytokines in the 
peripartum is the administration of phyto-extracts with anti-inflammatory effects. 
Tedesco et al. (2004) administered silymarin to periparturient dairy cows, a natural 
acknowledged hepato-protector (10 g as water suspension from -10 to 15 days from 
calving). They noticed beneficially effects of the treatment on lactation 
performances and body condition without pointing out any adverse effect. Trevisi et 
al. (2008) obtained promising results with an extract of Echinacea angustifolia 
administered per os from 30 days before calving through 14 days after it. In 
particular, positive effects were shown on the response to inflammation (lower 
reduction of -APP) and on the immune system (lower levels of neutrophils after 
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calving and lower neutrophil/lymphocytes ratio), with improvements in energy 
balance, milk yield and composition. 
Another possibility of intervention is represented by the administration of 
essential long chain fatty acids protected from the rumen bio-hydrogenation in the 
diet of periparturient dairy cows. Conjugated linoleic acid (CLA) was shown to have 
beneficial effects on inflammatory status and energy balance (Trevisi et al., 2009), on 
milk yield (Bernal-Santos et al., 2003), but it may exert a depressive effect on the 
production of milk fat (Baumgard et al., 2001). Moreover, the administration of ω3 
fatty acids in the diet showed positive effects in several experiments on 
periparturient dairy cows, e.g. Moussavi et al. (2007) displayed improvements on 
milk production and on feed intake, while Petit et al. (2006) had a good effect on 
fertility. 
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INFLAMMATION, AN OVERVIEW 
GENERAL MECHANISMS OF INFLAMMATION 
Despite it is very hard to find a brief and complete definition of inflammation 
(Scott et al., 2004), it may be defined as the reaction of a living tissue (or an organ) 
due to physical, chemical or biological nature harmful stimuli (stressors), including 
all the changes in the distal vascular bed (microcirculation) of blood and connective 
tissue, aiming to eliminate the cause and to repair damaged tissue. Distinctive signs 
of inflammation are well-known since very long time, and were described for the 
first time by Aulus Cornelius Celsus (I century AD) as rubor, tumor, calor, dolor. About 
a century later Galen of Pergamon, a Greek physician, surgeon and philosopher, 
added to these definitions a fifth one, functio laesa (disturbance of function; Rather, 
1971). All these terms refer to clear and perceptible conditions, which nowadays we 
can refer precisely to physiological events. Rubor, latin term for reddening, is due to 
active and passive tissular hyperaemia, a condition of highly filled vessel due to a 
greater blood influx and to haemoconcentration (inspissatio sanguinis), causing a 
reduced blood influx up to stasis. Tumor (swelling) rises later and derives part from 
hyperaemia and part from the exudate accumulation. The last sign, dolor (pain), is 
caused by the action of swelling on nerve endings. All these events trigger the functio 
laesa, term that describes compromised function of the tissue or organ hit by 
inflammation. 
The whole mechanism involves a number of biochemical mediators and causes 
cellular alterations, whose extent is usually related to the initial cause. After this 
cause, pro-inflammatory cytokines are released, and the vascular system and 
inflammatory cells are activated. These responses in turn are associated with the 
production of more cytokines and other inflammatory mediators which diffuse to 
the extracellular fluid compartment and circulate in the blood. The cytokines 
activate receptors on different target cells leading to a systemic reaction resulting in 
the activation of the hypothalamic-pituitary-adrenal axis, reduction of growth 
hormone secretion and a number of physical changes clinically characterized by 
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fever, anorexia, negative nitrogen balance and catabolism of muscle cells (Gruys et 
al., 2005). Nevertheless, an activation of the inflammatory response may be altered 
and excessive, causing a negative effect on the organism. 
The acute phase response (APR) is a prominent systemic reaction of the 
organism to local or systemic disturbances in its homeostasis caused by infection, 
tissue injury, trauma or surgery, neoplastic growth or immunological disorders 
(Gordon et al., 1985; Gruys et al., 1998). The acute phase is characterized by the 
rapid influx of blood granulocytes, typically neutrophils, followed swiftly by 
monocytes that mature into inflammatory macrophages that subsequently 
proliferate and thereby affect the functions of resident tissue macrophages (Ricciotti 
et al., 2011). In blood, a number of variations in proteins (acute phase proteins) can 
be observed, mainly due to the altered hepatic metabolism (Cousins, 1985; 
Dinarello, 1983; Gruys et al., 1994). During this response, liver is engaged in the 
production of the positive acute phase proteins (+APP), whose plasma level 
increases at the expense of the proteins usually synthesized, which decrease 
(negative acute phase proteins; -APP). 
EICOSANOIDS FROM Ω6 FATTY ACIDS AS MEDIATORS OF 
INFLAMMATION 
Several causes may trigger a set of reactions at local level producing small 
molecules like cytokines and eicosanoids. Eicosanoids are 20-carbon fatty acids 
mostly derived from arachidonic acid (20:4 ω-6), considered the primary eicosanoid 
precursor in mammalian cells (Funk, 2001). Following different pathways various 
classes can be originated the most important are prostaglandins (PGs), leukotrienes 
(LTs), lipoxins (LXs) and thromboxanes (TXs). Every eicosanoid exerts its specific 
action: for example PGI2 (prostacyclin) is a potent inhibitor of platelet aggregation, 
PGE2 induces pain, heat and fever, TXA2 stimulates platelet aggregation and PGF2α 
is known for its positive effect on oxytocin release. 
These molecules play a fundamental role in the duration and intensity of 
inflammatory response (Kinsella et al., 1990; Tilley, 2001) and can be divided 
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according to their activity, in more or less pro-inflammatory eicosanoids. 
Prostaglandin class mostly derive from arachidonic acid (20:4 ω-6; ARA) that, 
through two different pathways involving 5-lypooxygenase (LOX) and 
cyclooxigenase-2 (COX-2) enzymes, generates several mediators (e.g. hydroperoxy-
eicosatetraenoic acid and prostaglandin from 2 and 4 series; Calder, 2006) that exert 
the maximum pro-inflammatory activities. In competition with ARA cascade, two 
other cascades independent and parallel, originate from eicosapentaenoic acid (EPA; 
20:5 ω3) and dihomo-γ-linoleic acid (DGLA; 20:3 ω-6). EPA (more important) and 
DGLA (less important) cascades result mainly in the production of eicosanoids 
characterized by a weaker pro-inflammatory activity (series 1, 3, 5 PG, TX, LT). 
Moreover, docosahexaenoic acid (DHA; 22:6 ω3), an important EPA-derived fatty 
acid, can compete for COX-2 and LOX enzymes, forming mediators (protectins 
and resolvins D series) taking part in the resolution phase of inflammation ( Serhan 
et al., 2006). Ultimately, an increase in ω3/ARA ratio means higher incorporation of 
ω3 fatty acids in phospholipids at the expense of ARA, resulting in a decreased 
production of more pro-inflammatory eicosanoids. 
According to this mechanism, an adequate supplementation of long chain ω3 
fatty acids before inflammatory events, may be useful to optimize the inflammatory 
response and to reduce its adverse effects by changing PG production ratio, as 
previously suggested (Calder, 2002; Mori et al., 2004). Polyunsaturated fatty acids, 
and in particular long chain ω3 may be potential tools able to modulate the response 
to inflammatory phenomena (Calder, 2005). 
INFLAMMATION RESOLUTION 
The mechanisms of inflammation resolution remained unclear for decades, but 
recently a number of studies gave some light on this important phase. A number of 
mediators is involved in this process: their origin, action, and pathways have been 
recently clarified (Ariel et al., 2007). 
The resolution phase begins already a few hours after the beginning of 
inflammatory response, when granulocytes promote the switch of arachidonic acid–
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derived prostaglandins and leukotrienes to lipoxins, initiating the termination 
sequence of their recruitment. When the recruitment of neutrophils is stopped, the 
programmed death of these cells (apoptosis) takes place. At the same time ω3 
polyunsaturated fatty acids give origin to a number of mediators named resolvins 
and protectins, which critically shorten the period of neutrophil infiltration by 
initiating apoptosis. Apoptotic neutrophils are then cleared by macrophages and 
anti-inflammatory and reparative cytokines are released (e. g. transforming growth 
factor- β1, TGF- β1). The last step of resolution phase (and of the overall 
inflammatory response) is the departure of macrophages through the lymphatics 
(Serhan et al., 2005). 
Action of non-steroidal anti-inflammatory drugs 
Non-steroidal anti-inflammatory drugs (NSAIDs) is a class of drugs exerting their 
action through the inhibition of prostaglandins production. The first studies on 
these compounds were carried out in the XIX century by Maclagan (1876), who 
reported the beneficial effects of salicylic acid in the treatment of rheumatisms. In 
the following years the company of Frederick Bayer was actively engaged in finding 
a derivative characterized by an efficacy as good as the salicylic acid. Some time 
later, the molecule of acetylsalicylic acid was shown effective and was given the 
name “Aspirin” by the Bayer’s chief pharmacologist Heinrich Dreser (1899). About 
a century later Vane (1971) for the first time described the connection between 
aspirin and cyclooxygenase (COX) activity and consequently to the prostaglandin 
metabolism. A recent review of the same author (Vane, 2003) summarizes all the 
studies carried out in the following years on different species and experimental 
designs which confirmed his theories. 
A homogeneous, enzymatically active cyclooxygenase or prostaglandin 
endoperoxide synthase (PGHS) was isolated in 1976 (Hemler et al., 1976) and it is 
found in greatest amounts in the endoplasmic reticulum of prostanoid-forming cells 
(Smith, 1986). It exhibits COX activity that both cyclizes arachidonic acid and adds 
the 15-hydroperoxy group to form prostaglandin G2 (PGG2). The hydroperoxy 
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group of PGG2 is reduced to the hydroxy group of PGH2 by a peroxidase. Both 
COX and hydroperoxidase activities are contained in the same dimeric protein 
molecule. Aspirin selectively acetylates the hydroxyl group of one serine residue (Ser 
530) located 70 amino acids from the C terminus of the enzyme (Roth et al., 1975). 
This acetylation leads to irreversible COX inhibition; thus, a new enzyme must be 
synthesized before more prostanoids are produced. When the purified enzyme is 
acetylated, only the COX, not the hydroperoxidase, activity is inhibited. The 
stoichiometry of this reaction is 1:1, with one acetyl group transferred per enzyme 
monomer of this dimeric protein. At low concentrations, aspirin acetylates PGHS 
rapidly (within minutes) and selectively. At high concentrations, over longer time 
periods, aspirin will also non-specifically acetylate a variety of proteins and nucleic 
acids (Smith, 1989). Acetylation of the enzyme by aspirin places a bulky substituent 
on the Ser 530 oxygen that inhibits binding of arachidonic acid (DeWitt et al., 1990). 
Synergic action of aspirin and ω3 fatty acids on eicosanoids production 
Considering the results showed above, the efficacy of the simultaneous 
administration of aspirin together with ω3 fatty acids may be evaluated on the 
eicosanoids metabolism (Engström et al., 2001). Serhan et al. (2002) reported as in 
several experiments on different species the administration of EPA and DHA in 
combination with aspirin gave origin to the 17R-hydroxy-DHA, that is transformed 
by neutrophils into two sets of novel di- and tri-hydroxy products (resolvins, Rv) 
which exert an inhibitory effect on some cytokines. Later, Arita et al. (2005) gave 
some further explanations on resolvins and their functions. Resolvin E1 (RvE1) is 
biosynthesized in vivo from EPA via trans-cellular biosynthetic routes during cell–
cell interactions, and thus it is formed in vivo during multicellular responses such as 
inflammation and microbial infections. RvE1 protects tissues from leukocyte-
mediated injury and counter-regulates pro-inflammatory gene expression. These 
newly identified Rv may underlie the beneficial actions of ω3 PUFAs especially in 
chronic disorders where unresolved inflammation is a key mechanism of 
pathogenesis.  
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AIM OF THE THESIS 
The transition period of dairy cows is still the most important phase of their 
productive cycle, when most of pathologies, and probably the most severe, appear. 
The inflammatory response is a mechanism that occurs after several kind of stimuli 
(e.g. infections, trauma) with the purpose to remove the injurious stimuli and to 
initiate the healing process. Nevertheless, it causes also an extra effort for the whole 
body that subtracts energy and nutrients from other primary functions (e.g. milk 
production, reproduction). In the periparturient dairy cow, it could be very harmful, 
in particular if too strong and prolonged. 
In order to avoid negative consequences, first of all it is important to limit the 
occurrence of inflammatory processes adopting correct procedures (e.g. 
vaccinations, hoof trimming, to avoid digestive disturbs and other metabolic 
diseases, besides any kind of stress factors). However, whenever they take place, the 
key is to make the body less responsive to inflammation and in any case to promptly 
treat with specific drugs. Thus, the main issues of this thesis are: 
a) to identify a combination of markers able to assess both the inflammatory 
status around calving and the cow’s response to it. According to previous 
attempts, carried out in the past with a similar purpose, our aim has been to 
set up a new index characterized by an easy application in field conditions; 
b) to verify the possibility to reduce the consequences of inflammation by using 
some of the tools already proposed in literature: 
 in the first experiment algae-derived ω3 fatty acids were administered 
daily from three weeks before through three weeks after calving; 
 in the second one fish-derived ω3 fatty acids were administered the last 3 
weeks of pregnancy alone or in combination with lysine acetylsalicylate 
(last 7 pregnancy days) to take advantage of their well-known effects, as 
well as their supposed synergic actions against inflammation. 
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  Chapter 1: Introduction 
INTRODUCTION 
Inflammation is a process mediated by the release of pro-inflammatory cytokines 
after an external stimulus (e.g. infections, trauma) that may occur at any time 
(Feghali and Wright, 1997). In some physiological stages inflammation is a common 
occurrence. In particular, it is demonstrated that dairy cows suffer an inflammatory 
condition during their transition period (Cappa et al., 1989), that exerts several 
negative effects on metabolism, performances and fertility (Trevisi et al., 2011). The 
level of inflammation may be very different among cows, and only a part of them 
show clinical signs together with the inflammatory status. Thus, several cows appear 
clinically healthy but may suffer a subclinical inflammatory status (Bertoni et al., 
2008) demonstrated by the important raise of the positive acute phase proteins 
(Gruys et al., 2005; Murata, 2004; Petersen et al., 2004). 
The mechanism of inflammation triggers the release of a number of mediators, 
such as eicosanoids and cytokines. In particular, cytokines exert many effects, some 
of which may cause detrimental consequences on some crucial aspects of the 
periparturient dairy cow life (e.g. anorexia, fever). Among the effects exerted by 
cytokines, it is important the action that triggers the production of +APP, causing 
the so-called acute phase response (APR). APR is not only characterized by the raise 
of the plasma levels of +APP, but also by the reduced production of some other 
proteins usually synthesized by the liver in normal conditions (-APP). The plasma 
changes of +APP are useful indices to describe the severity of the inflammatory 
status, while –APP describe the extent and the consequences of the response to 
inflammation. However, it is a common believe that the consideration of single 
plasma parameters may be insufficient to evaluate the whole complexity of the 
inflammatory event and its consequences. Thus, some attempts have been done in 
the past to set up indices considering different parameters: Bonnefoy et al. (1998) 
proposed an index (Prognostic Inflammatory and Nutritional Index, PINI) useful to 
score the overall health of humans considering two blood markers of inflammatory 
(C-reactive protein and alpha(1)-acid glycoprotein) and of nutritional (albumin and 
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transthyretin) states. Their aim was to forecast hospital mortality and outcome of 
patients hospitalized in an acute geriatric unit. Toussaint et al. (1995) suggest the use 
of an Acute Phase Index (API) to better describe the inflammatory status and 
consequently to give further elements to assess the quality of slaughtered animals. 
Gruys et al. (2005) proposed another index composed either by +APP and –APP, 
the Nutritional and Acute Phase Indicator, NAPI = (value of a rapid positive APP 
× value of a slow positive APP)/(value of rapid negative APP × value of a slow 
negative APP). 
Trevisi et al. (2001) and Bertoni et al. (2006) proposed two new indices (Liver 
Activity Index, LAI and Liver Functionality Index, LFI) that contributes to give an 
idea of the extent of the inflammatory response in dairy cows during the first month 
of lactation. The main limitation of these indices is the delay of assessment: a result 
is available only one month after calving, when several negative effects are already 
spent. Thus, the aim of this research was to identify a new index able to evaluate 
both the severity of the inflammatory status occurring after calving in the 
periparturient dairy cow and its consequences, selecting the most proper parameters 
with the statistical support of the principal component analysis. The secondary aim 
is a simplification and a shortening of the time of diagnosis (at 7 DIM, 3 weeks 
earlier than LFI and LAI), in order to make it easily applicable in a field situation. 
MATERIALS AND METHODS 
This study complied with Italian and European rules on animal experimentation 
and ethics. 
BARN CHARACTERISTICS, ANIMALS AND TREATMENTS 
This work involved 56 cows reared in the experimental barn of the Università 
Cattolica (CERZOO) located in the Northern Italy (Piacenza) over 3 years. Cows 
were reared in loose stall with cubicles and milked twice a day (12 hours gap). 
Sufficient space was available as number of cubicles and manger places to avoid any 
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competition for feed and/or rest. Cows were checked for the last month of 
pregnancy through the first of lactation as described in the next paragraph, and 
underwent a similar management and suffered similar stress factors due to sample 
collection. Dry and lactating cows were fed once a day two different TMR, which 
only underwent slight changes in the years due to different lots of the same feed 
(Table 1). 
CLINICAL CHECKS 
During the experiment, animals health conditions were checked every day by 
general inspections and monitored by a computerized Afimilk system (S.A.E. 
Afikim, Kibbutz Afikim, Israel), based on automatic recording of activity and milk 
production through a leg transponder. Cows underwent a thorough gynecological 
examination at about 10 and 30 DIM, or when required by a suspect of pathology. 
Each cow was submitted to the following assessments: 1) Body condition scoring, 
using a 5-point scale (ADAS, 1986), starting about 35 d before the expected calving 
date and, then, every 14 days to 35 DIM. 2) Milk yield and its conductivity, 
measured and recorded by the Afimilk computer-controlled automated system at 
every milking. 3) Blood samples, collected approximately at -28, -21 (pre-treatment), 
-14, -10, -7, -3 (before calving), 1 (day after calving), 3, 7, 10, 14, 21, 28, 35 (post-
treatment) days from calving. Every sample was collected in the morning before 
feeding, from a jugular vein in two vacuum tubes (Vacuette, Greiner Bio-One 
GmbH, Kremsmunster, Austria) containing lithium-heparin as anticoagulant. Tubes 
were cooled immediately after collection in an ice-water bath until their arrival in 
laboratory. After a small aliquot of blood was taken to determine packed cell 
volume (centrifugation at 12000 RPM for 11 minutes), tubes were centrifuged at 
3520 × g for 16 minutes at 4°C; plasma samples were divided in 5 aliquots, stored at 
-20°C (4) or -80°C (1). On these samples were determined: I) Inflammatory 
response indexes: positive acute phase proteins (+APP; haptoglobin, ceruloplasmin) 
and negative acute phase proteins (-APP; albumin, cholesterol as lipoprotein index). 
II) Liver indexes: total bilirubin , aspartate amino-tranferase (GOT), γ-glutamil 
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transferase (GGT), alkaline phosphatase (ALP), paraoxonase (PON). III) Energy 
metabolism indexes: glucose, NEFA, BHB. IV) Protein metabolism indexes: urea, 
creatinine. V) Oxidative stress response: total reactive oxygen metabolites (ROM). 
VI) Minerals (Ca, P, Mg, Na, K, Cl, Zn). VII) Vitamins (assayed only on 41 cows): 
retinol (index of its carrier protein), tocopherol, β-carotene. VIII) Other parameters 
(total proteins, globulins). 
Glucose, total protein, albumin, total cholesterol, total bilirubin, creatinine, urea, 
Ca, P, Mg, GOT, GGT and ALP were detected at 37°C by a clinical auto-analyzer 
(ILAB 600, Instrumentation Laboratory, Lexington, MA) using commercial kits 
purchased by Instrumentation Laboratory (IL Test), at the conditions described in 
Appendix 2. Globulins were calculated as the difference between total protein and 
albumin. Electrolytes (Na+, K+, and Cl−) were detected by the potentiometer 
method (Ion Selective Electrode connected to ILAB 600). Zn and NEFA were 
determined by commercial kits (Wako Chemicals GmbH, Neuss, Germany). 
Haptoglobin, BHB, and ceruloplasmin were analyzed using methods described by 
Bertoni et al. (1998), adapted to ILAB 600 conditions. Plasma retinol, tocopherol 
and β-carotene were extracted with hexane and analyzed by reverse-phase HPLC 
using Spherisorb ODS-2.3 µm, in a 150 × 4.6 mm column (Alltech, Deerfield, IL); a 
UV detector set at 325 nm (for retinol) or 290 nm (for tocopherol); and 80:20 
methanol:tetrahydrofurane as the mobile phase. ROM were measured using a 
method patented by Diacron International S.r.l. (Grosseto, Italy) and expressed as 
mg of hydrogen peroxide per 100 mL of plasma. Plasma PON activity was assessed 
by adapting the method of Ferré et al. (2002) to the ILAB 600, as described by 
Bionaz et al. (2007). 
DATA HANDLING AND STATISTICAL ANALYSIS 
All data in this paper are presented in the form mean ± standard deviation. 
The days relative to calving are reported as classes, thus their variability is ± 3 
days. 
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Principal component analysis (PCA) 
To perform the choice of the parameters involved in the index and the best day 
of sampling, the statistical analysis of the principal component (PRINCOMP 
procedure, SAS Inst. Inc., Cary, NC) was carried out considering as variables the 
plasma concentrations of the main parameters involved in the inflammation after 
calving (at 3, 7, 10 DIM). In the Table 3 are reported the eigenvalues (which 
quantify the variability explained by every single component as a percentage of the 
total variability explained by all the components involved in the model) of the two 
principal components. The most important parameters found on principal 
component 1 (negatively correlated) were: haptoglobin at 7 DIM (-0.27) and ROM 
at 7 DIM (-0.26). On the same principal component, but positively correlated are 
found PON at 10 DIM (0.33), PON at 7 DIM (0.31), cholesterol at 10 DIM (0.30) 
and cholesterol at 7 DIM (0.26). 
Index construction 
Every cow was assigned a score for each parameter basing on extreme values 
given in Table 2. According to these extreme values, the linear equations for each 
parameter were calculated, in order to assign a score to the values of the parameters: 
Haptoglobin score = -8,33 × (haptoglobin value) + 12,5 
ROM score = -1,43 × (ROM value) + 25,7 
Cholesterol score = 10 × (cholesterol value) – 20 
PON score = 0,17 × (PON value) – 10 
The sum of the scores of the four parameters gives the final index named Post-
calving Inflammatory Response Index (PIRI): 
PIRI = haptoglobin score + ROM score + cholesterol score + PON score 
The PIRI index assigns higher values to cows characterized by a less severe 
inflammation and by a lower consequences to inflammation.  
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Analysis of variance 
The cows were ranked according their score and divided in tertiles. A statistical 
analysis was carried out to verify significant differences among tertiles for every 
checked parameter: data were submitted to repeated measures variance analysis 
using a mixed model (MIXED procedure, SAS Inst. Inc., Cary, NC; Littell et al., 
1998). Before analysis the normality of distribution was verified for each parameter 
through skewness and kurtosis calculation according to the Shapiro test (SAS Inst. 
Inc.). When necessary, data were normalized through logarithmic (ALP, 
haptoglobin, BHB), root-square (bilirubin, NEFA) or inverse (GOT) 
transformations. 
The layout of our statistical model can be summarized as follows: 
Yiklm = μ + Gi + Tk + GTik + Bl(im) + eiklmn 
where Yijklm = mth observation of the lth cow Bl within the ith tertile Gi, at the kth 
day relative to calving Tk; μ = total average; Gi = effect of the ith tertile; Tk = effect 
of the kth day relative to calving (the number of levels being defined as a function of 
pregnancy phase and actual variable); GTik = effect of the interaction between the ith 
tertile and the kth day relative to calving; Bl(im) = effect of the lth cow within the ith 
tertile; eiklmn = random effect or error. 
Calculation of other indices 
The Liver Functionality Index (Bertoni et al., 2008) was calculated for the same 
set of cows of PIRI index, while the Liver Activity Index (Bertoni et al., 2006) was 
calculated on only 41 cows out of 56. A simple correlation with PIRI index was 
calculated for these two indices. 
RESULTS 
Post-calving Inflammatory Response Index. The whole population of cows presented an 
averaged PIRI score of 22.74±7.96. The correlation between PIRI index and LFI 
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index (Table 4) was r = 0.60 (P<0.001), while between PIRI and LAI was r = 0.55 
(P<0.001). 
To investigate the possible usefulness of this index, cows were ranked according 
to its value and divided in tertiles: LO-PIRI, IN-PIRI and HI-PIRI. The average 
PIRI scores (Table 4) were: 13.76±4.29 in LO-PIRI, 23.33±1.49 in IN-PIRI and 
31.17±3.59 in HI-PIRI. In the next sections are described the main differences 
found between LO-PIRI and HI-PIRI tertiles. IN-PIRI tertile will be mentioned 
only in case its trend differed from the median level. 
Health status and performances. As shown in Table 5, more cows in LO-PIRI (n = 7) 
suffered post-calving health troubles than in the other tertiles (n = 5 in IN-PIRI and 
n = 2 in LO-PIRI). Furthermore, the total problems suffered by LO-PIRI cows was 
10, while HI-PIRI cows suffered only 3 post-calving health issues. The LO-PIRI 
cows showed a more marked drop of BCS (Figure 2) from 14 days to calving to 35 
DIM (-0.57±0.17 points vs -0.43±0.15 points in HI-PIRI; P<0.01). The total milk 
yield in the first 28 days of lactation was higher in HI-PIRI (1050±136 kg) than in 
LO-PIRI (966±172 kg). The daily production (Figure 1) was significantly higher in 
HI-PIRI cows than in LO-PIRI cows between 7 and 14 DIM, with the widest 
difference recorded at 8 DIM (37.7±4.9 kg/d in HI-PIRI vs 33.2±6.1 kg/d in LO-
PIRI; P<0.05). 
Inflammatory status parameters. Some of these parameters (haptoglobin, ROM, 
cholesterol, PON; Figures 11, 15, 4, 14) are included in the PIRI index, and 
significant differences between extreme tertiles are expected at least immediately 
after calving as a consequence of the PIRI calculation method. In the first 10 days 
of lactation all the four parameters showed significant differences between LO-PIRI 
and HI-PIRI, and some of these parameters were different also later. Moreover, 
cholesterol, PON and ROM showed statistically significant differences already 
before calving. In detail, the plasma concentrations of haptoglobin (Figure 11) 
before calving kept average values <0.3 g/L, while immediately after calving the 
levels increased in all the tertiles reaching a peak at 3 DIM. LO-PIRI had a stronger 
increase, with higher levels from the day after calving to 10 DIM (0.16±0.13 g/L in 
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HI-PIRI vs 0.69±0.38 g/L in LO-PIRI at 7 DIM; P<0.001). ROM (Figure 15) 
showed a general tendency to increase after calving, keeping higher levels during 
lactation in respect to pregnancy. HI-PIRI showed during all the considered period 
lower plasma concentrations in respect to LO-PIRI. In particular, the maximum 
difference was found at 3 DIM (11.25±2.29 mg H2O2/100 mL in HI-PIRI vs 
15.22±2.55 mg H2O2/100 mL in LO-PIRI; P<0.001). Cholesterol (Figure 4) 
showed in all cows the usual decreasing trend in late pregnancy, followed by a 
recovery during the first month of lactation. HI-PIRI cows showed higher levels 
already at the beginning of the experimental period (3.11±0.69 mmol/L in HI-PIRI 
vs 2.62±0.59 mmol/L in LO-PIRI; P<0.05 at 28 days before calving), and kept the 
difference until the end. However, the difference was wider starting from 7 DIM 
(2.56±0.44 mmol/L in HI-PIRI vs 1.88±0.38 mmol/L in LO-PIRI; P<0.001). 
Paraoxonase (Figure 14) showed a general trend similar to cholesterol. The levels 
were higher in HI-PIRI than in LO-PIRI for the whole experiment, and reached the 
maximum gap after calving (120.36±25.48 U/mL in HI-PIRI vs 69.08±18.09 U/mL 
in LO-PIRI at 10 DIM; P<0.001). 
Among the parameters related to inflammation not included in the PIRI index, 
particularly interesting are the trends of ceruloplasmin (Figure 5), which showed a 
similar trend between LO-PIRI and HI-PIRI, with an increase immediately after 
calving followed by a slight reduction. HI-PIRI cows kept lower values for all the 
checked period, and at 7 DIM the values were 3.11±0.39 µmol/L in HI-PIRI and 
3.55±0.68 µmol/L in LO-PIRI (P<0.05). Albumin (Figure 7) did not show any 
difference between groups in late pregnancy. After calving, its plasma concentration 
dropped in LO-PIRI cows much more than in HI-PIRI, and showed also a delayed 
recovery. The greatest difference was found at 10 DIM (37.16±1.40 g/L in HI-PIRI 
vs 34.72±3.32 g/L in LO-PIRI; P<0.001). The values of retinol (Figure 16) 
decreased in the last month of pregnancy, reaching the minimum immediately after 
calving and then recovering the pre-calving levels. HI-PIRI kept higher levels than 
LO-PIRI for the whole checked period. The difference was maximum at 7 DIM 
(43.71±11.87 µmol/L in HI-PIRI vs 25.87±5.21 µmol/L in LO-PIRI; P<0.001). 
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Bilirubin (Figure 9) started an increasing trend some weeks before calving in all the 
cows, and peaked in LO-PIRI at 1 DIM (9.14±6.14 mmol/L), while in HI-PIRI the 
peak was achieved 3 days after calving (4.63±2.03 mmol/L). The difference 
between HI-PIRI and LO-PIRI was significant between 14 days before calving to 
10 days after it and maximum gap was observed at 1 DIM (4.63±2.03 mmol/L in 
HI-PIRI vs 9.14±6.14 mmol/L in LO-PIRI; P<0.001). 
Energy metabolism parameters. Glucose (Figure 3) showed a tendency to be higher in 
HI-PIRI at 7 DIM (3.69±0.26 mmol/L in HI-PIRI vs 3.41±0.83 mmol/L in LO-
PIRI; P<0.10). NEFA levels (Figure 12) increased in all cows around calving, 
peaking at 3 DIM. LO-PIRI cows showed a stronger increase around calving and 
the level of NEFA turned out significantly higher from 3 days before calving to 10 
DIM. The maximum difference between tertiles was observed the day after calving 
(0.47±0.21 mmol/L in HI-PIRI vs 0.99±0.47 mmol/L in LO-PIRI; P<0.001). BHB 
(Figure 13) showed a similar trend around calving in all the tertiles, starting to 
increase 3 days before calving and peaked at 3 DIM. In HI-PIRI, BHB was 
significantly lower: 0.75±0.15 mmol/L in HI-PIRI vs 1.28±0.89 mmol/L in LO-
PIRI (P<0.01). 
Other plasma parameters. Globulin (Figure 8) showed during the first month of 
lactation higher levels in LO-PIRI, with the maximum difference reached at 14 DIM 
(38.78±4.85 g/L in HI-PIRI vs 43.53±5.36 g/L in LO-PIRI; P<0.01). ALP (Figure 
10) displayed significantly higher levels in HI-PIRI already 28 days before calving 
(58.31±13.41 U/L in HI-PIRI vs 42.12±20.69 U/L in LO-PIRI; P<0.01) and kept 
the significance until calving. In the first month of lactation it tended to be higher in 
HI-PIRI until 28 DIM, while at 35 DIM values were similar. Urea, Ca, P, Mg, Na, 
K, Cl, Zn, GOT, GGT, creatinine did not show any statistical differences among 
tertiles. 
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DISCUSSION 
The new index was set up in order to create a field-applicable tool mainly to 
identify the cows characterized by subclinical pathologies before these result in 
severe metabolic damages to the cow.  
Effectiveness of PIRI in the detection of inflammation severity. The application of PIRI 
index to the set of 56 cows showed that LO-PIRI suffered more health problems 
after calving than HI-PIRI cows (Table 5) and the values of haptoglobin (Figure 11), 
ceruloplasmin (Figure 5), ROM (Figure 15) and bilirubin (Figure 9) showed that the 
inflammatory status in LO-PIRI was more marked than in HI-PIRI. Retinol (Figure 
16), cholesterol (Figure 4) and PON (Figure 14) showed that the LO-PIRI cows 
suffered more severe consequences of inflammation. Interestingly in LO-PIRI cows 
the pre-calving plasma concentrations of cholesterol and PON were already 
significantly lower and ROM significantly higher than in HI-PIRI cows. This may 
imply a different starting situation of the cows, with a predisposition of LO-PIRI 
cows to be affected by health issues. The partition of cows according to PIRI index 
showed as the cows which suffered milder inflammation had an higher milk yield, as 
previously shown by Bertoni et al. (2006). Interestingly, the same cows were also 
characterized by a lower lipomobilization suggested by the lower BCS drop (Figure 
2) and confirmed by the significantly higher post-calving plasma concentrations of 
NEFA and BHB (Figures 12 and 13). The higher levels of glycaemia (Figure 3) in 
the first week after calving confirmed a better picture of energy metabolism in HI-
PIRI cows. 
Comparison with other complex indices: LAI and LFI. Considered the effectiveness of 
the index to split the cows according to the severity of their inflammatory status, 
was evaluated its affinity to other indices which had similar purposes. Although the 
highly significance of the correlation, the good but not very high values of r (r = 
0.60 with LFI and r = 0.55 with LAI) suggest that PIRI describes something partly 
different from what LAI and LFI describe. Indeed, PIRI includes some parameters 
characterized by different significances, e.g. haptoglobin as an indicator of 
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inflammatory status and ROM, involved in the oxidative stress. Furthermore, the 
plasma concentration of these parameters is considered at different times (only 7 
DIM in PIRI vs trend in the first month of lactation in LFI and LAI). Thus, the 
PIRI index aims to assess also the severity of the inflammatory status and not only 
its consequences (as it was in LFI and LAI). However, an implication of PIRI may 
be the identification as “problem animals” the subjects that are later able to recover 
by themselves, anyway an eventual treatment given to these animals may speed the 
recovery up. 
Field applicability of the PIRI index. In comparison to LFI and LAI, the PIRI index 
is able to promptly identify cows with inflammatory problems at the beginning of 
lactation, while LFI and LAI give a result only after the end of the first month of 
lactation. In particular, PIRI is useful to identify animals with subclinical health 
problems that might later worsen and show clinical pathologies after 7-10 DIM. 
Such these cows could in this way be treated since the second week of lactation in 
order to prevent the occurrence of more severe pathologies. 
CONCLUSION 
The results reported show that the Post-calving Inflammatory Response Index is 
a useful tool to identify cows affected by inflammatory problems in the first days 
after calving. In particular its structure takes into account either the inflammatory 
status (+APP) and its consequences (-APP), allowing a better assessment of the 
whole inflammatory event in respect to the previous indices LFI and LAI which 
only considered -APP. The fairly good correlation with LFI and LAI, considered the 
differences in the composition of the indices, suggests that also PIRI could be a 
good index to describe inflammation in post-calving of dairy cows. 
Furthermore, an important improvement is the possibility to have a response 
already at 7-10 days after calving, allowing to take early the needed decisions on 
eventual proper treatments or drug administration. However, LFI and LAI may give 
later a better description of the inflammatory status suffered by the cow during the 
first month of lactation. 
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The extent of the population considered in this work to set up the index was 
good, but all cows were from the same barn. To give PIRI more strength and to 
have a further and stronger validation, it is necessary the involvement of more cows 
from different farms.  
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COMPONENTS [% of DM] Dry cows Lactating cows
Grass hay 49.63 7.37
Alfalfa hay - 11.64
Wheat straw 16.5 -
Corn silage 25.6 32.9
Corn meal (67%) and corn flakes (34%) - 24.85
Cottonseed - 8.68
Soybean meal 7.4 -
Mineral and vitamin supplementation
§ 0.9 -
Commercial concentrate
# - 14.56
CHEMICAL COMPOSITION
NEL [Mcal/kg of DM] 1.29 1.58
CP [% of DM] 12.44 16.11
NDF [% of DM] 56.57 33.88
Starch + sugar [% of DM] 12.58 26.83
Ether extract [% of DM] 1.91 4.79
Table 1 - Nutritional values of the diets fed as TMR for close-up and
lactating cows. Small fluctuation of these values are expected due to
different lots
§
42.9% Ca2PO4; 28.6% urea; 14.3% MgO; 7.1% NaCl; 7.1% mineral and
vitamin supplement (1500000 IU/kg vitamin A; 150000 IU/kg vitamin D;
7000 IU/kg vitamin E; 10 mg/kg Co; 70 mg/kg I; 1100 mg/kg Mn; 500
mg/kg Cu; 23 mg/kg Se; 4000 mg/kg Zn)
#
58800 IU/kg vitamin A; 5200 IU/kg vitamin D; 102 IU/kg vitamin E; 0.4
mg/kg Co; 2.4 mg/kg I; 150 mg/kg Mn; 35 mg/kg Cu; 0.5 mg/kg Se; 150
mg/kg Zn
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Parameter Max score = 10 Min score = 0
Haptoglobin 0.3 1.5
ROM 11 18
Cholesterol 3 2
PON 120 60
PARAMETER DIM PRIN1 PRIN2
PON 7 0.3357 0.0315
PON 10 0.3274 -0.0016
Retinol 7 0.3235 -0.0513
Retinol 3 0.2902 -0.0777
Albumin 10 0.2864 0.1569
PON 3 0.2620 0.0620
Albumin 7 0.2477 0.1744
Cholesterol 7 0.1817 -0.1690
Cholesterol 10 0.1809 -0.1924
Zn 3 0.1653 0.0542
Zn 7 0.1575 0.1661
Ceruloplasmin 7 0.1035 0.3690
Ceruloplasmin 10 0.0880 0.3444
Cholesterol 3 0.0757 -0.2281
Zn 10 0.0709 0.1397
Ceruloplasmin 3 0.0673 0.3021
Albumin 3 0.0578 0.1079
ROM 10 0.0200 0.3426
ROM 7 -0.0307 0.3653
ROM 3 -0.0762 0.2803
Bilirubin 10 -0.0885 0.1633
Bilirubin 7 -0.1581 0.1269
Haptoglobin 3 -0.1780 0.0400
Haptoglobin 10 -0.1925 0.0415
Bilirubin 3 -0.2284 0.1489
Haptoglobin 7 -0.2520 0.0922
Table 3 - Eigenvalues from PCA analysis sorted by PRIN1 values
Table 2 - Values for each parameter included in
PIRI index assigned maximum (10) and
minimum (0) scores
50
PIRI LFI LAI
MEAN 13.76 -2.22 -0.38
SD 4.29 3.18 0.35
MEAN 23.33 -0.89 -0.06
SD 1.49 2.58 0.64
MEAN 31.17 1.26 0.36
SD 3.59 1.61 0.28
CORRELATIONS
r P<
PIRI-LFI 0.60 0.0001
PIRI-LAI 0.55 0.0001
LO-PIRI
IN-PIRI
HI-PIRI
Table 4 - Mean values of PIRI index in every
tertile and mean values of LFI and LAI for the
same tertiles of PIRI. Correlations among
PIRI, LFI and LAI
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MILK FEVER RP METRITIS MASTITIS KETOSIS
HI-PIRI 1 1 1 - -
IN-PIRI 1 1 3 - -
LO-PIRI 1 2 3 2 2
PIRI N. OF COWS LFI N. OF COWS
HI-PIRI 2 HI-LFI 5
IN-PIRI 5 IN-LFI 2
LO-PIRI 7 LO-LFI 7
Table 5 - Count of clinical health problems found in each tertile of cows and count of animals affected by
problems; comparison with LFI index
52
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
DIM 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30
HI-PIRI vs LO-PIRI * * * * + + + +
HI-PIRI vs IN-PIRI
IN-PIRI vs LO-PIRI
Figure 1 - Milk yield [kg/d] of dairy cows divided in tertiles according to their score of Post-calving Inflammatory
Response Index (PIRI). HI-PIRI = higher values; IN-PIRI = intermediate values; LO-PIRI = lower values.
20
25
30
35
40
45
0 7 14 21 28
days in milk 
LO-PIRI
IN-PIRI
HI-PIRI
53
Figure 2 - Trend of body condition score (BCS) of dairy cows divided in tertiles
according to their score of Post-calving Inflammatory Response Index (PIRI).
HI-PIRI = higher values; IN-PIRI = intermediate values; LO-PIRI = lower
values.
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Figure 3 - Pattern of changes of glucose [mmol/L] in plasma collected in the
morning before feeding from periparturient dairy cows divided in tertiles
according to their score of Post-calving Inflammatory Response Index (PIRI). HI-
PIRI = higher values; IN-PIRI = intermediate values; LO-PIRI = lower values.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
DIM
HI-PIRI vs LO-PIRI
HI-PIRI vs IN-PIRI
IN-PIRI vs LO-PIRI
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-28 -21 -14 -10 -7 -3 1 3 7 10 14 21 28 35
* * + * * * * ** *** *** *** *** *** ***
+ * * ** *
+ + + + + + + + *IN-PIRI vs LO-PIRI
Figure 4 - Pattern of changes of cholesterol [mmol/L] in plasma collected in the
morning before feeding from periparturient dairy cows divided in tertiles
according to their score of Post-calving Inflammatory Response Index (PIRI). HI-
PIRI = higher values; IN-PIRI = intermediate values; LO-PIRI = lower values.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
DIM
HI-PIRI vs LO-PIRI
HI-PIRI vs IN-PIRI
1
2
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4
5
-28 -21 -14 -7 0 7 14 21 28 35
days relative to calving 
HI-PIRI
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-28 -21 -14 -10 -7 -3 1 3 7 10 14 21 28 35
* * * + **
+ * ** + * * + **
Figure 5 - Pattern of changes of ceruloplasmin [µmol/L] in plasma collected in
the morning before feeding from periparturient dairy cows divided in tertiles
according to their score of Post-calving Inflammatory Response Index (PIRI). HI-
PIRI = higher values; IN-PIRI = intermediate values; LO-PIRI = lower values.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
DIM
HI-PIRI vs LO-PIRI
HI-PIRI vs IN-PIRI
IN-PIRI vs LO-PIRI
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+ + +
** * +
IN-PIRI vs LO-PIRI
Figure 6 - Pattern of changes of total protein [g/L] in plasma collected in the
morning before feeding from periparturient dairy cows divided in tertiles
according to their score of Post-calving Inflammatory Response Index (PIRI). HI-
PIRI = higher values; IN-PIRI = intermediate values; LO-PIRI = lower values.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
DIM
HI-PIRI vs LO-PIRI
HI-PIRI vs IN-PIRI
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-28 -21 -14 -7 0 7 14 21 28 35
days relative to calving 
HI-PIRI
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+ *** ** ** *** *
+ * + ** **
+
Figure 7 - Pattern of changes of albumin [g/L] in plasma collected in the morning
before feeding from periparturient dairy cows divided in tertiles according to their
score of Post-calving Inflammatory Response Index (PIRI). HI-PIRI = higher
values; IN-PIRI = intermediate values; LO-PIRI = lower values.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
DIM
HI-PIRI vs LO-PIRI
HI-PIRI vs IN-PIRI
IN-PIRI vs LO-PIRI
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+IN-PIRI vs LO-PIRI
Figure 8 - Pattern of changes of globulin [g/L] in plasma collected in the morning
before feeding from periparturient dairy cows divided in tertiles according to their
score of Post-calving Inflammatory Response Index (PIRI). HI-PIRI = higher
values; IN-PIRI = intermediate values; LO-PIRI = lower values.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
DIM
HI-PIRI vs LO-PIRI
HI-PIRI vs IN-PIRI
30
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days relative to calving 
HI-PIRI
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+ * * + *** ** ** **
+ * +
*** + +
Figure 9 - Pattern of changes of bilirubin [mmol/L] in plasma collected in the
morning before feeding from periparturient dairy cows divided in tertiles
according to their score of Post-calving Inflammatory Response Index (PIRI). HI-
PIRI = higher values; IN-PIRI = intermediate values; LO-PIRI = lower values.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
DIM
HI-PIRI vs LO-PIRI
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IN-PIRI vs LO-PIRI
Figure 10 - Pattern of changes of alkaline phosphatase [U/L] in plasma collected
in the morning before feeding from periparturient dairy cows divided in tertiles
according to their score of Post-calving Inflammatory Response Index (PIRI). HI-
PIRI = higher values; IN-PIRI = intermediate values; LO-PIRI = lower values.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
DIM
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Figure 11 - Pattern of changes of haptoglobin [g/L] in plasma collected in the
morning before feeding from periparturient dairy cows divided in tertiles
according to their score of Post-calving Inflammatory Response Index (PIRI). HI-
PIRI = higher values; IN-PIRI = intermediate values; LO-PIRI = lower values.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
DIM
HI-PIRI vs LO-PIRI
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* *** *** ** *IN-PIRI vs LO-PIRI
Figure 12 - Pattern of changes of NEFA [mmol/L] in plasma collected in the
morning before feeding from periparturient dairy cows divided in tertiles
according to their score of Post-calving Inflammatory Response Index (PIRI). HI-
PIRI = higher values; IN-PIRI = intermediate values; LO-PIRI = lower values.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
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Figure 13 - Pattern of changes of β-hydroxybutyric acid [mmol/L] in plasma
collected in the morning before feeding from periparturient dairy cows divided in
tertiles according to their score of Post-calving Inflammatory Response Index
(PIRI). HI-PIRI = higher values; IN-PIRI = intermediate values; LO-PIRI =
lower values.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
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Figure 14 - Pattern of changes of paraoxonase [U/mL] in plasma collected in the
morning before feeding from periparturient dairy cows divided in tertiles
according to their score of Post-calving Inflammatory Response Index (PIRI). HI-
PIRI = higher values; IN-PIRI = intermediate values; LO-PIRI = lower values.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
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Figure 15 - Pattern of changes of total Reactive Oxygen Metabolites [mg
H2O2/100 mL] in plasma collected in the morning before feeding from
periparturient dairy cows divided in tertiles according to their score of Post-calving
Inflammatory Response Index (PIRI). HI-PIRI = higher values; IN-PIRI =
intermediate values; LO-PIRI = lower values.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
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Figure 16 - Pattern of changes of retinol [µmol/L] in plasma collected in the
morning before feeding from periparturient dairy cows divided in tertiles
according to their score of Post-calving Inflammatory Response Index (PIRI). HI-
PIRI = higher values; IN-PIRI = intermediate values; LO-PIRI = lower values.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
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ABSTRACT 
The aim of this research was to study the consequences of ω3 fatty acids (FA) 
administration around calving on inflammatory response and on productive 
performances. In this period dairy cows undergo a metabolic challenge, coming with 
an inflammatory-like status triggering the release of pro-inflammatory mediators 
(e.g. eicosanoids, cytokines). Eicosanoids synthesis may be modulated by altering 
the ratio of their precursors (ω3 and ω6 FA). Ten cows received 22 g/d of rumen-
protected ω3 FA from -21 to +21 days from calving (OPT), while 10 (CTR) 
received no supplement. Cows were frequently monitored for health status, body 
condition score (BCS), blood (metabolic, inflammatory and FA profiles), milk yield. 
OPT (vs CTR) showed a similar milk production, a numerically smaller BCS drop, 
lower postpartum levels of non-esterified fatty acids (P<0.05), β-hydroxybutyric acid 
(P<0.1) and creatinine (P<0.05), suggesting a milder post-calving reserves 
mobilization. All cows underwent an inflammatory condition around calving, but 
OPT showed a milder response, as suggested by lower levels of bilirubin (P<0.05), 
and by the higher level of Liver Functionality Index (P<0.10). Plasma concentration 
of ω3 FA (eicosapentaenoic and docosahexaenoic acids) increased in OPT during 
treatment (P<0.01 vs CTR). Since ω3 FA are the main replacers of arachidonic acid 
in membrane phospholipids, their increased levels in plasma of OPT cows may have 
cut the formation of arachidonic-derivatives (pro-inflammatory mediators), 
countering the beginning of the inflammation. Hence, the administration of rumen-
protected ω3 FA in transition period seems to attenuate the effects of subclinical 
inflammations and to improve the energy balance. 
INTRODUCTION 
The endocrine-immune-metabolic system of periparturient dairy cows is strongly 
challenged and cows are often unable to react properly. For this reason, cows in 
their first two months of lactation undergo the highest frequency of metabolic (e.g. 
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milk fever, ketosis, liver lipidosis) and infectious diseases (Goff et al., 1997; LeBlanc 
et al., 2006). The latter often occurs after calving and seems mainly related to the 
inability of cows to readily adapt their biologic systems to the new situation, causing 
an increased susceptibility to environmental stimuli (e.g. stress, pathogens, feeding 
changes; Drackley et al. 2005). In any case, these troubles can induce the release of 
pro-inflammatory cytokines (e.g. IL-1; IL-6, TNF-
reduced appetite, fever, increased energy expenditures and fat mobilization (Elsasser 
et al., 1995). In addition, the ability of cows to increase their feed intake at the 
beginning of lactation is much lower than milk yield rise, resulting in a marked 
negative energy balance that cause a noticeable lipomobilization (Drackley, 1999; 
Drackley et al., 2001). These events can trigger new and more serious pathologies as 
well as many endocrine-metabolic modifications. Indeed, pro-inflammatory 
cytokines could reiterate the inflammatory phenomena, if not promptly stopped 
(Dinarello, 2000), and the organism’s reaction of response to such a negative 
situation may be harmful itself if too strong and long. 
Periparturient cows, even without clinical signs, experience an inflammatory-like 
condition around calving, shown by the marked rise of positive acute phase proteins 
at calving or immediately after, as well as the reduction of negative acute phase 
proteins (Bionaz et al., 2007; Bertoni, 2008). Moreover, we recently demonstrated 
that cows with higher pro-inflammatory cytokines before calving (Trevisi et al., 2009; 
Trevisi et al., 2011), had also lower levels of feed intake, milk yield and some 
negative acute phase proteins (–APP). Some attempts to modulate inflammatory 
response in this critical period have been done. Non-steroidal anti-inflammatory 
drugs (NSAIDs) administration in post-partum period improved both metabolic 
status and performance of dairy cows (Trevisi et al., 2005; Trevisi et al., 2008). On 
the contrary, the oral administration of IFN-α (a suggested anti-inflammatory 
cytokine) in the last three weeks of pregnancy (Trevisi et al., 2009) failed to display 
any metabolic or performance improvement. The issue still remains relevant in the 
management of dairy cows, therefore additional tools able to modulate 
inflammatory response, avoiding negative aspects and keeping positive ones, are 
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needed. In this respect, potential candidates might be the conjugated linoleic acid 
(Butz et al. 2007; Ringseis et al. 2008), phytoextracts (Choi et al., 2003; Trevisi et al., 
2008), and polyunsaturated fatty acids (Calder, 2006a; Ballou et al., 2009), in 
particular the long chain ω3. 
These fatty acids are involved in the modulation of the inflammatory process; ω3 
can mitigate the inflammatory response, by decreasing the formation of pro-
inflammatory prostaglandins (series 2 and 4), as well as minimizing the formation of 
the Nuclear Factor kB (NFkB; Rimbach et al., 2002; Thurnham, 2004). This nuclear 
factor enhances the gene expression leading to the formation of pro-inflammatory 
cytokines and cyclooxygenases (COX; i.e. enzymes producing eicosanoids, 
mediators of inflammation). Antioxidants (e.g. flavonoids), another class of 
nutraceutical substances able to relieve the inflammatory process, also use a 
mechanism that inhibits COX-2 activity (O'Leary et al., 2004). However, not always 
ω3 fatty acids (FA) have been shown to be effective in this regard. Farran et al. 
(2008) administered flax seed to steers and observed an increase of ω3 FA plasma 
level but, after LPS challenge, no significant effects on haptoglobin and fibrinogen 
were evenly observed. Ballou et al. (2009) administered unprotected fish oil to 
periparturient dairy cows and observed an increase of ω3 FA concentration in liver 
phospholipids, but unfortunately no parameters related to inflammatory status were 
assessed in this research. 
Furthermore, the occurrence of an inflammatory stimulus triggers a set of 
reactions at local level producing several mediators, like cytokines (proteins) and 
eicosanoids (prostaglandins=PG, leukotrienes=LT, lipoxins=LP and 
thromboxanes=TX, lipids). These molecules play a fundamental role in the 
regulation of the duration and intensity of inflammatory response (Kinsella et al., 
1990; Tilley, 2001) and can be divided according to their activity, in anti- and pro-
inflammatory eicosanoids. Prostaglandins mostly derive from arachidonic acid (20:4 
ω6; ARA) that, through two different pathways involving 5-lypooxygenase (LOX) 
and COX-2 enzymes, generates several mediators (e.g. hydroperoxy-eicosatetraenoic 
acid, prostaglandin from 2 and 4 series; Calder, 2006) that exert pro-inflammatory 
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activities. In competition with ARA cascade, two other cascades originated from 
eicosapentaenoic acid (EPA; 20:5 ω3) and dihomo-γ-linoleic acid (DGLA; 20:3 ω6), 
involved in the production of eicosanoids with anti-inflammatory (or less 
inflammatory) activity (series 1, 3, 5 PG, TX, LT). Moreover, docosahexaenoic acid 
(DHA; 22:6 ω3), an important EPA-derived fatty acid, can compete for COX-2 and 
LOX enzymes, forming mediators (protectins and resolvins of D series) taking part 
in the resolution phase of inflammation. Therefore, a reduction in ω6/ω3 ratio 
means higher incorporation of ω3 FA in phospholipids at the expense of ω6, 
resulting in a decrease of pro-inflammatory eicosanoids production. According to 
this mechanism, an adequate supplementation of long chain ω3 FA before 
inflammatory events, seems useful to optimize the inflammatory response and to 
reduce its adverse effects by changing PG production ratio, as previously suggested 
(Calder, 2002; Mori et al., 2004). In this context, it appears noteworthy to investigate 
the effects of the prolonged administration of long chain ω3 FA before and during 
the inflammatory challenge. Thus, the aim of the research was to examine the role 
of these ω3 FA administered from 3 weeks before to 3 weeks after calving on the 
common inflammatory response occurring during the peripartum of dairy cows and 
on their physiological adaptation and performances. 
MATERIALS AND METHODS 
This study complied with Italian and European rules on animal experimentation 
and ethics. 
BARN CHARACTERISTICS, ANIMALS AND TREATMENT 
The trial took place in the Università Cattolica experimental barn (CERZOO) 
located in the Northern Italy (Piacenza) during autumn-winter season and involved 
20 multiparous Friesian dairy cows reared in loose stall with cubicles and milked 
twice a day (12 h gap). Dry and lactating cows were fed with two different TMR 
diets described in Table 1. Cows housed in the same pen and with low somatic cell 
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count at dry off were attributed to two homogeneous groups, according to body 
condition, calving period, production potential, parity body weight. The first one 
(n=9, OPT) received an algae-derived oil administration of 112.5 g/cow/d, 
corresponding to 250 g/cow/d of commercial product (Optimate, Agritech, 
Tipperary, Ireland; imported and distributed by Cosapam Soc. Coop. S.r.l. Peschiera 
Borromeo, Italy). The supplement was individually offered to each cow, without any 
possibility of competition and it was completely ingested in a few minutes. It was 
fed once a day immediately before the TMR distribution, mixed with about 0.5 kg of 
fresh cows TMR. The administration of algae-derived oil started around the 21st day 
before the expected calving date and lasted until 21 days in milk (DIM). CTR cows 
(n=11) were also daily captured as OPT group and before calving received 0.75 kg 
of fresh cows TMR. 
The oil was rumen-protected by the NET (Nutrient Enrobing Technology; 
Agritech, Tipperary, Ireland) technology. The whole detailed FA composition of the 
product is described in Table 2. The daily administration contained per cow about 
18.5 g of ω3 (34.5% of EPA, 34.1% of DHA, 31.4% others) and 5.5 g of ω6 FA, 
with an ω6/ω3 ratio of 0.3. Noteworthy is the presence of 4000 IU/kg of vitamin E 
in the supplement, which corresponds to an administration of 1000 U/cow/d. 
CLINICAL CHECKS 
During the experiment, the animals health conditions were checked every day by 
general inspections and monitored by a computerized Afimilk system (S.A.E. 
Afikim, Kibbutz Afikim, Israel), based on automatic recording of activity and milk 
production through a leg transponder. In addition, rectal temperature was measured 
the day after calving and twice a week from 14 day before to 14 days after calving. 
Cows were also submitted to a thorough gynecological examination at about 10 and 
30 DIM. The dry matter intake of dry and lactating cows pens was fortnightly 
estimated. Moreover, each cow was submitted to the following assessments: I) body 
condition scoring, using a 5-point scale (ADAS, 1986), starting about 35 days before 
the expected calving date and, then, every 14 days to 42 DIM; II) milk yield and its 
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conductivity, measured and recorded by the Afimilk computer-controlled automated 
system at every milking; III) milk samples at 7, 14, 28, 42 DIM, from the morning 
milking, in order to assess fat, protein and lactose content (MilkoScan FT 120, Foss 
Electric, Hillerød, Denmark), and somatic cell count (SCC; Fossomatic 180, Foss 
Electric); iv) blood samples, collected approximately at -28, -21 (pre-treatment), -14, 
-10, -7, -3 (before calving), 1 (day after calving), 3, 7, 10, 14, 21 (end of treatment), 
28, 35, 42 (post-treatment) days from calving.  
Every sample was collected in the morning before feeding, from a jugular vein 
and in two vacuum tubes (Vacuette, Greiner Bio-One GmbH, Kremsmunster, 
Austria), one containing lithium-heparin as anticoagulant, and the other silicon (no 
anticoagulant). Lithium-heparin tubes were cooled immediately after collection in an 
ice-water bath until their arrival in laboratory. After a small aliquot of blood was 
taken to determine packed cell volume (centrifugation at 12000 RPM for 11 min), 
tubes were centrifuged at 3520 × g for 16 min at 4°C; plasma samples were divided 
in 5 aliquots, stored at -20°C (n=4) or -80°C (n=1).  
In accordance with Bionaz et al. (2007) on these samples were determined: I) 
inflammatory response indexes: positive acute phase proteins (+APP; haptoglobin, 
ceruloplasmin) and negative acute phase proteins (-APP; albumin, cholesterol as 
lipoprotein index); II) liver indexes: total bilirubin, aspartate amino-tranferase 
(GOT), γ-glutamil transferase (GGT), alkaline phosphatase (ALP), paraoxonase 
(PON); III) energy metabolism indexes: glucose, non-esterified fatty acids (NEFA), 
β-hydroxybutyrate (BHB); IV) protein metabolism indexes: urea, creatinine (Finco, 
1997); V) oxidative stress response: total reactive oxygen metabolites (ROM); VI) 
minerals (Ca, P, Mg, Na, K, Cl, Zn); VII) vitamins: retinol (index of its carrier 
protein; Blomhoff et al., 1987; Erikstrup et al., 2009), tocopherol, β-carotene; VIII) 
other parameters (total proteins, globulins). 
Glucose, total protein, albumin, total cholesterol, total bilirubin, creatinine, urea, 
Ca, P, Mg, GOT, GGT and ALP were detected at 37°C by a clinical auto-analyzer 
(ILAB 600, Instrumentation Laboratory, Lexington, MA, USA) using commercial 
kits purchased by Instrumentation Laboratory (IL Test), as previously described by 
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Bionaz et al. (2007). Globulins were calculated as the difference between total 
protein and albumin. Electrolytes (Na+,K+, and Cl−) were detected by the 
potentiometer method (Ion Selective Electrode connected to ILAB 600). Zn and 
NEFA were determined by commercial kits (Wako Chemicals GmbH, Neuss, 
Germany). Haptoglobin, BHB, and ceruloplasmin were analyzed using methods 
described by Bertoni et al. (1998), adapted to ILAB 600 conditions. Plasma retinol, 
α-tocopherol and β-carotene were extracted with hexane and analyzed by reverse-
phase HPLC using Spherisorb ODS-2.3 µm, in a 150 × 4.6 mm column (Alltech, 
Deerfield, IL, USA); a UV detector set at 325 nm (for retinol) or 290 nm (for 
tocopherol); and 80:20 methanol:tetrahydrofurane as the mobile phase. ROM were 
measured using a method patented by Diacron International S.r.l. (Grosseto, Italy) 
and expressed as mg of hydrogen peroxide per 100 mL of plasma. Plasma PON 
activity was assessed by adapting the method of Ferré et al. (2002) to the ILAB 600, 
as described by Bionaz et al. (2007). Plasma FA were detected in plasma at -21, -3, 
21 and 42 days from calving and expressed as % of total FA measured in 
accordance with the method described by Visioli et al. (2003): for first lipids were 
extracted (Folch et al., 1957) and quantified by microgravimetry. Later, FA methyl 
esters were prepared from total lipids extracts, and their plasma concentrations were 
determined by gas chromatography made quantitative by the use of 19:0 and 21:0 as 
internal standards. 
DATA HANDLING AND STATISTICAL ANALYSIS 
All data in this paper are presented in the form: mean ± standard deviation. 
Eight cows (5 in CTR and 3 in OPT) received antibiotic and/or anti-
inflammatory treatments, thus they have been excluded from the statistical analysis. 
Data were submitted to repeated measures variance analysis using a mixed model 
(MIXED procedure, SAS Inst. Inc., Cary, NC; Littell et al., 1998). Before analysis 
the normality of distribution was verified for each parameter through skewness and 
kurtosis calculation according to the Shapiro test (SAS Inst. Inc.). When necessary, 
data were normalized through logarithmic (cholesterol, haptoglobin, BHB, DHA), 
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quadratic (glucose, milk production, % ω3 HUFA/total HUFA) or root-square 
(bilirubin, DHA/ARA ratio) transformations. For body condition score (BCS) 
analysis, the initial value was used as covariate. 
The layout of our statistical model can be summarized as follows: 
Yiklm = μ + Gi + Tk + GTik + Bl(im) + eiklmn 
where Yijklm = mth observation of the lth cow Bl within the ith treatment Gi, at the 
kth time to calving Tk; μ = total average; Gi = effect of the ith treatment (2 
treatments: OPT and CTR); Tk = effect of the kth time to calving (the number of 
levels being defined as a function of pregnancy phase and actual variable; levels were 
thus respectively 15, 50, and 8 for blood parameters, milk production, and BCS 
data); GTik = effect of the interaction between the ith treatment and the kth time to 
calving; Bl(im) = fixed effect of the lth cow within the ith treatment; eiklmn = random 
effect or error. 
The analysis was carried out using 3 covariance structures: Autoregressive, 
Compound symmetry, and Spatial Power. These were ranked according to their AIC 
(Akaike’s Information Criterion; Akaike, 1974), choosing as better the lowest one 
(Littell et al., 1998). For each treatment, least squares means were computed, and 
preplanned pairwise comparisons (PDIFF option, SAS Inst. Inc.) were carried out 
when the F-test of one of the main factors (time, treatment, treatment×time) was 
significant at P<0.10. Statistical significance was designated as P<0.05, tendencies 
were declared at P<0.10. 
In order to assess the different response of each cow to inflammatory status 
during the first month of lactation, two complex indexes (Liver Functionality Index, 
LFI and Liver Activity Index, LAI) were calculated, basing on some blood 
parameters related to inflammation. LFI (Bertoni et al., 2006) considers blood 
changes of albumin, lipoproteins (measured as total cholesterol) and total bilirubin 
(its clearance enzymes are synthesized by the liver) from the 3rd to the 28th DIM. 
LFI calculation is carried out in 2 steps; the first one considers the values of the 
three parameters observed at 3 DIM (V3) and changes between 3 and 28 (V28) 
DIM. For albumin and cholesterol these two components equally concurred (50%) 
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to the partial LFI result (Alb-I and Chol-I =0.5×V3+0.5× (V28-V3)), while for 
bilirubin the level at 3 DIM represents 67% and the reduction between 3 and 28 
DIM the remaining 33% of the partial LFI index (Bili-I=0.67×V3+0.33× (V28-
V3)). In the second step, these partial indexes were standardized according to 
average values observed in healthy cows, and LFI was calculated according to the 
following formula: 
LFI = [(albumin index – 17.71)/1.08 + (cholesterol index – 2.57)/0.43 – 
(bilirubin index – 6.08)/2.17]. 
The LAI index (Bertoni et al., 2008) includes the average blood level at 7, 14 and 
28 DIM of some proteins synthesized by the liver: albumin, lipoproteins (measured 
as total cholesterol), and Retinol Binding Protein (RBP, measured as retinol). Data 
of these 3 blood parameters were transformed into units of standard deviation 
obtained for each cow as follows: the mean value of the herd population of each 
plasma parameter (albumin, total cholesterol, and RBP) was subtracted from each 
cow value at 7, 14, and 28 DIM and divided by the corresponding standard 
deviation. The final LAI value of each cow is the result of the arithmetical mean of 
all the partial values. Thus, low LFI or LAI values are associated with a large 
inflammatory response and vice versa. 
Finally, Pearson correlations (PROC CORR of SAS) among all parameters were 
calculated for the whole period considering OPT and CTR cows. 
RESULTS 
HEALTH STATUS 
Approximately 40% of animals showed at least one severe clinical health problem 
during the experiment: 3 metritis, 1 retained placenta, 1 mastitis, 1 milk fever in 
CTR group (5 cows) and 2 metritis and 2 retained placenta in OPT group (3 cows). 
All these cows received antibiotic and/or anti-inflammatory treatments, thus they 
have been excluded from the statistical analysis. The frequency of severe health 
problems seems similar in the two groups, thus their origin should not be due to the 
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treatment. The inclusion of these animals in the analysis could have been cause of 
high data variability, especially for blood parameters of inflammation. In particular 
the excluded cows showed very high levels of haptoglobin and bilirubin around the 
clinical symptoms, followed by a reduction after drug treatments. Therefore, results 
will be discussed on 6 animals for each group which showed no clinical problems or 
just with mild and short-lived troubles (not affecting plasma indexes of 
inflammation), and which did not receive any drug treatment. Average milk 
production and body condition score are not significantly affected by the exclusion 
of ill cows. 
FEEDING 
Individual dry matter intake was not recorded, but the mean feed intake of dry 
cows (about 12.5 kg/d) and of lactating cows (about 23.5 kg/d) observed during the 
trial were near the requirements suggested by NRC (2001). In the weeks closest to 
calving intakes were likely much lower. The diets fed during the experiment are 
shown in detail in Table 1. 
PERFORMANCE 
No significant differences were found in milk yield: the mean in the first month 
of lactation was 37.5±3.1 in CTR vs 37.9±3.5 kg/d in OPT. Somatic cell count 
remained very low in all the cows, demonstrating a healthy mammary status during 
the trial (80±68 in CTR vs 30±10 cells/µl in OPT). No relevant differences between 
groups were detected in the milk lactose and protein content. Milk fat was 
numerically lower in OPT group until the 28 DIM (3.57±0.62 vs 4.04±0.97 % of 
CTR) and statistically different at 7 DIM (3.92±0.69 vs 4.99±0.51 % in CTR; 
P<0.05). 
At the beginning of the experiment (-28 day before calving), mean BCS was close 
to the expected value for that period (2.5-3.0 points; ADAS, 1986). After calving, 
BCS showed in both groups a drop. However, the fall was numerically greater in 
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CTR, resulting in a marked decrease from 3 days before the calving to 42 DIM (-
0.63±0.17 and -0.49±0.23 points in CTR and OPT respectively; NS). 
Rectal temperatures did not show any difference between the two groups, with a 
general mean value of 38.9°C from 14 days before calving to 14 DIM. No cows 
showed fever (temperature higher than 39.5°C). 
BLOOD PARAMETERS 
Energy and protein metabolism indexes 
Glucose trend was characterized by the typical decrease after calving. Levels 
(Figure 1) were steady and similar in both groups until 21 days before calving (on 
average 4.15±0.21 mmol/L). From 14 days before calving CTR group started 
decreasing, while OPT remained steady until 3 days before calving and then fell. At 
3 DIM the difference between groups was the greatest (3.85±0.27 in OPT vs 
3.18±0.73 mmol/L in CTR; P<0.05), but subsequently disappeared.  
Before ω3 FA administration, BHB and NEFA levels were similar in the two 
groups. Approaching the calving, NEFA level (Figure 1) increased in both groups, 
but more markedly in CTR. The maximum difference of NEFA between groups 
was reached 3 days before calving (0.38±0.19 in OPT vs 0.77±0.38 mmol/L in CTR; 
P<0.01), then the difference gradually disappeared. At -10 DIM, BHB showed a 
very strong increase in CTR group, but not in OPT. BHB in CTR achieved a peak at 
3 DIM (1.62±1.48 vs 0.57±0.10 mmol/L in OPT), while in OPT peaked at 10 DIM 
(0.94±0.78 mmol/L). Despite the large numerical differences between the groups, 
BHB did not show any statistically significant difference. This result may be due to 
the large data variability caused by the presence, immediately after calving, of some 
subclinical cases of ketosis (cows with at least one value ≥1.2 mmol/L; Goff et al., 
1997): 3 cows in CTR and one in OPT. 
Creatinine gradually increased before calving in CTR while remained quite stable 
in OPT (104.6±10.6 in OPT vs 118.6±10.7 mmol/L in CTR at 7 days before 
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calving; P<0.05). After calving creatinine decreased in both groups, but quicker in 
CTR and statistical differences between groups disappeared from 7 DIM. 
Inflammatory status indexes 
Among +APP, haptoglobin (Figure 2) showed in both groups low and steady 
values until calving (<0.1 g/L); then the typical peak occurred at 3 DIM (0.56±0.42 
in OPT vs 0.69±0.31 g/L in CTR; NS). OPT levels had a quicker recovery to pre-
calving values and remained lower than in CTR during the whole lactation period, 
but no significant differences were observed. Ceruloplasmin trend was similar 
between the two groups during pregnancy (2.56±0.32 in OPT vs 2.59±0.58 μmol/L 
in CTR, mean of the last month of pregnancy; NS). After calving CTR showed a 
numerically higher level of ceruloplasmin, and the difference vs OPT progressively 
increased (3.03±0.36 in OPT vs 3.27±0.42 μmol/L in CTR at 7 DIM; NS). 
Globulins showed numerically higher levels in CTR starting from 7 days before 
calving with increasing difference to 42 DIM (NS), while ROM did not show any 
difference. 
Among –APP, albumins levels (Figure 3) were similar before the beginning of the 
ω3 FA administration in the two groups. During transition period the general trends 
were similar between groups: gradual decrease during the last 3 weeks of pregnancy 
and first DIM and then progressive raise. Nevertheless, in CTR the reduction was 
quicker and the recovery slower than in OPT, implying numerically lower levels 
than OPT in the first month of lactation. Cholesterol level (Figure 2) was similar in 
the groups before ω3 FA supplementation. Ten days before calving, cholesterol 
level became statistically higher in OPT (P<0.05) vs CTR. After calving the 
difference between groups increased, showing statistically significance until 35 DIM 
(5.58±0.65 in OPT vs 4.50±0.50 mmol/L in CTR; P<0.05). Bilirubin may also be 
considered as an index of the protein systems synthesized by the liver, since its 
clearance relies on some of these proteins. Bilirubin showed a similar pattern of 
changes in both groups, nevertheless, its level in OPT was lower during the whole 
experiment. Around calving (from 10 days before calving to +3 DIM) the difference 
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vs CTR increased and it became statistically significant, mainly immediately after 
calving (6.21±4.11 in OPT vs 10.11±5.52 mmol/L in CTR; P<0.05 at 3 DIM). Also 
retinol (index of Retinol Binding Protein) displayed the typical drop at calving time 
in all the cows, followed by a recovery. OPT group showed a numerically quicker 
increase after calving (NS). 
LFI and LAI indexes 
LFI is an aggregate index of the liver functionality and considers the changes of 
some negative acute phase reactants. In OPT group, LFI showed a mean value of 
1.69±2.18, while in CTR group had a negative mean value: -1.33±3.23 (P<0.10). 
Despite the high variability, OPT had only one cow characterized by a negative 
value of LFI index, whereas CTR showed only two cows with a positive LFI value. 
LAI index confirms the above-mentioned results (0.17±0.79 in OPT vs -0.17±0.47 
in CTR), but the difference between the groups appeared to be lower. 
Other parameters 
Plasma tocopherol level (Figure 3) was similar before the experiments in the two 
groups. In OPT, tocopherol showed a slight rise after the beginning of the ω3 FA 
administration, while markedly decreased in CTR, turning out significantly different 
(2.72±0.59 in OPT vs 1.53±0.64 μg/mL in CTR; P<0.001 at 3 days before calving). 
After calving tocopherol fell down also in OPT group, and the difference 
disappeared at the 3rd DIM. Subsequently, tocopherol level increased faster in ω3-
supplemented cows and the difference between groups rose from 7 to 14 DIM 
(2.27±0.58 in OPT vs 1.56±0.16 μg/mL in CTR; P<0.05 at 14 DIM). At 21 DIM, 
end of the ω3 administration, the difference between the two groups was no more 
significant, but the level remained numerically higher in OPT until 28 DIM. 
Considering all cows and the whole period, plasma tocopherol resulted well 
correlated with cholesterol (r=0.62; P<0.01). 
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Plasma fatty acids 
In Table 3 are presented the changes of plasma FA during the experiment. As 
expected, plasma levels of the most important ω3 FA (EPA and DHA; Figure 4) 
increased during their dietary administration and turned out higher in OPT than in 
CTR for about the whole administration period, while were similar before. In detail, 
EPA reached the highest level before calving (1.08 vs 0.53 % of plasma FA in CTR 
at 3 days before calving), while DHA maintained a higher level for all the 
supplementation period (P<0.001 until 21 DIM) and a tendency 14 days after the 
suspension of treatment (0.12 vs 0.05 % of plasma FA in CTR, at 42 DIM, P<0.10). 
Moreover, also docosapentaenoic acid (DPA, 22:5 ω3) – interconverted between 
EPA and DHA (Bénistant et al., 1996) – was higher in OPT group during the ω3 
administration, but it reached a statistical evidence only at 21 DIM (0.52 vs 0.74 % 
of plasma FA in CTR, P<0.05). Anyway, the ω3 fatty acid present in the largest 
amount (73% of all ω3) in plasma was the α-linolenic acid (ALA, 18:3 ω3): 3.89 % of 
all plasma FA on average for the whole period and all cows. ALA (Table 3) was 
similar between groups at 21 days before calving (pre-treatment data item); after the 
beginning of the administration, it reached numerically higher levels in the OPT 
group, keeping the difference for the whole following period (NS). Three days 
before calving, ALA level in plasma showed a marked increase in both groups 
(4.96±0.14 in OPT vs 4.71±1.01 % of plasma FA in CTR, NS). After calving ALA 
decreased to levels lower than in the dry period. Considering all cows and the whole 
period, ALA was correlated with cholesterol (r=0.67; P<0.01) and thus with 
lipoproteins. DHA/ALA ratio (Agostoni et al., 2008), an index of the whole ω3 FA 
pathway, was equal in the two groups before and after treatment. With the 
beginning of the ω3 administration, DHA/ALA increased in OPT group until 21 
DIM, when it reached a statistically significant difference (0.09±0.01 vs 0.03±0.01 in 
CTR; P<0.001). Summarizing all data on FA and taking in account the total plasma 
ω3 Highly Unsaturated Fatty Acids (HUFA), which include FA with number of 
C≥20 (EPA, DPA, DHA) out of all the determined FA, OPT showed similar values 
to CTR before (21 days before calving) and after (+42) the FA administration, but 
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higher levels during treatment period (peak at 3 days before calving: 2.03±0.19 in 
OPT vs 1.15±0.32 % of all FA in CTR; P<0.01). Interestingly, the rate of ω3 HUFA 
on the total HUFA rose in both groups from -21 to -3 days to calving, but more 
markedly in OPT. OPT level continued to rise until the end of ω3 administration 
(+21 DIM), reaching a significant difference vs CTR (26.67 vs 19.55% of HUFA; 
P<0.01). At 42 DIM no differences were detected between groups. 
The rate of ω6 HUFA on the total HUFA showed an opposite outcome in 
respect to ω3 HUFA, but only with numerical differences between groups. The 
overall trend in all the cows showed the highest value 21 days before calving 
(7.75±0.68 % of all FA), a progressive prepartum drop and steady values until 42 
DIM (5.08±0.70 %). The two most important ω6 HUFA, DGLA (diomo-γ-linolenic 
acid) and ARA (arachidonic acid), followed a similar trend: a prepartum decrease, 
and a recovery after calving. Despite the similar trend, ARA level was numerically 
higher in CTR vs OPT at 42 DIM. Indeed, DGLA showed higher levels in OPT 
group since before the beginning of the experiment (P<0.05 at 21 days before 
calving) and kept a numerical difference for all the following period. 
DISCUSSION 
Our research mainly deals with plasma parameters related to metabolism and 
inflammation; unfortunately, the trend and variability of these parameters (and likely 
also others) are markedly modified by serious health problems. Hence, in order to 
reduce this kind of interference, cows suffering clinical problems (likely not 
ascribable to the treatment) were cut off (4 per group). 
OPT cows received 112.5 g/d of fat in addition to the diet. However, we did not 
check the individual feed intake and consequently it is not possible to determine the 
real differences in feed and energy intake among the cows. Thus our results may be 
influenced either by FA composition either by the energy intake, which is not only 
related to the supplement. 
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In our experiment, the use of algae-derived oil caused a slight reduction of milk 
fat content during the 1st month of lactation. This could be due to a partial release 
of unsaturated FA into the rumen caused by an inadequate protection, and 
consequently an incomplete biohydrogenation and trans FA production. As well 
known, the absorption of some trans FA in the gut cause the inhibition of milk fat 
synthesis in mammary gland (Bauman et al., 2000). This is in agreement with the 
results of Mattos et al. (2004), that administered to periparturient cows unprotected 
ω3 FA (128 g/d) and observed a lower milk fat content compared to a control 
group (4.35 vs 5.20 %). Nevertheless, the lower milk fat content in OPT could be 
partly due to the less strong lipolysis, as suggested by the lower levels of NEFA and 
the numerically smaller reduction of BCS in the first month of lactation, that 
supplied a lower amount of precursors for mammary fat synthesis. 
Despite the possible slight reduction of the ω3 FA availability in gut caused by 
this last event, we observed a general plasma increase of total ω3 FA in OPT group 
(P<0.01), especially before calving, confirming their absorption and their inclusion 
into the phospholipids of plasma lipoproteins. On the contrary, the CTR group 
showed a slight reduction at calving, in agreement with the trend previously shown 
by Bertoni et al. (2006). 
Within plasma ω3 FA, ALA was the most abundant, and similar in both groups; 
in fact the content of supplement is lower (Table 2) than the intake with feed. The 
significant correlation between ALA and cholesterol (an index of lipoproteins) 
during the experimental period confirms previous data (Bertoni et al., 2006). The 
well-known low level of ALA in adipose tissue (Christie, 1981; Seidlin, 1995), 
suggests that blood changes of this fatty acid depend mainly on phospholipids and 
not on triglyceride release from adipose tissue. 
EPA and DHA were the two ω3 FA supplemented in the largest and similar 
amount (Table 2): their plasma level increased during the administration period, but 
in different extent. DHA showed the greatest and prolonged raise (Figure 4), in 
accordance with data collected on non-lactating beef cows by Burns et al. (2003). 
Otherwise, EPA resulted increased only before calving and in OPT. It is difficult to 
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explain the decline of EPA alone at the beginning of lactation; in fact, previous data 
(Castañeda-Gutiérrez et al., 2007; Mattos et al., 2004) report as EPA and DHA are 
present in milk in a similar extent, and also their transfer rate from plasma to milk is 
low and similar. Despite the lack of data, this trend might be attributed to the EPA 
conversion into DHA through the Sprecher’s shunt (Sprecher, 2000), and the 
activation of this mechanism after calving might be related to the important 
metabolic-endocrine variations occurring at the onset of lactation. For these two FA 
the correlations with NEFA were not significant, while with cholesterol they turned 
out much lower than ALA (NS). This suggests that also EPA and DHA are not 
affected by lipomobilization. Moreover, we can argue that the reduction of EPA and 
DHA concentration in the plasma during post-calving ω3 supplementation could be 
due to the dilution of plasma lipid with NEFA from reserve triglycerides, which do 
not contain important amount of these ω3 FA (Bertoni et al., 2006a). 
Other important changes in the fatty acid profile concern the raise of plasma ω3-
HUFA on total HUFA, about 50% higher in comparison to the pre-administration 
level. The value of this index is much higher (15-21% in CTR and 18-26% in OPT) 
than in a previous trial carried on during mid-lactation (10-12%; Trevisi et al., 2009). 
This suggests a higher level of plasma ω3 HUFA in the current trial, likely due to 
different dietary intakes, both for the basic ration and for the higher 
supplementation. 
Almost all cows undergo a subclinical inflammatory status around calving, as well 
reported previously (Bionaz et al., 2007; Bertoni et al., 2008; Sordillo et al., 2009). In 
this experiment, despite we cut off subjects with serious clinical symptoms, CTR 
cows suffered more severe subclinical inflammatory conditions than OPT cows. In 
fact, both groups were characterized by a similar marked increase of +APP (i.e. 
haptoglobin and ceruloplasmin) after calving, but CTR displayed a delayed decrease 
of the +APP levels after the peak, sign of a slower return to normal conditions. 
Although not always statistically significant, the differences between groups in 
parameters directly (e.g. albumin, lipoproteins as total cholesterol, Retinol Binding 
Protein as vitamin A) or indirectly (e.g. bilirubin) related to –APP are consistent. In 
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detail, cholesterol (marker of lipoprotein) and retinol (marker of its carrier, Retinol 
Binding Protein) increased more slowly in CTR after calving; bilirubin (whose 
excretory enzymes are synthesized by liver; Kamisako et al., 2000) was significantly 
higher in CTR. Altogether, the data above mentioned confirm the greater deviation 
of usual hepatic synthesis of proteins in CTR compared to OPT group (e.g. slightly 
more +APP and much less –APP). Thus, in our experiment both groups suffered 
similar inflammations (see haptoglobin in Figure 1), whereas the response markedly 
differed between groups in terms of usual liver synthesis (Figures 2 and 3 for 
recovery of cholesterol and albumins), as confirmed by the better values of Liver 
Functionality Index observed in OPT cows, due to a quicker rise of –APP after the 
onset of the lactation. The marked rise of ω3 HUFA observed in OPT cows may be 
related to a less severe response to inflammation after calving. EPA and DHA are 
the main ω3-HUFA taking an action in anti-inflammatory activity, exerting a double 
beneficial effect in animal physiology. First, they are the main replacers of ARA in 
phospholipids (Calder, 2001) and are precursors for several molecules characterized 
by a weak pro-inflammatory action (i.e. prostaglandins, leukotrienes, thromboxane). 
These types of mediators contribute to decrease the production of pro-
inflammatory cytokines (Gruys et al., 2005), which is regulated by ARA products 
(Rola-Pleszczynski et al., 1992). Second, EPA and DHA are also involved in the 
production of more mediators (i.e. protectins and resolvins) of inflammation 
resolution phase (Serhan et al., 2005). To confirm this framework, Visioli et al. (2003) 
observed in human a relationship among the high level of plasma ω3, a reduced 
inflammation and a lower incidence of clinical and subclinical diseases. Thus, the 
increased plasma levels of EPA and DHA in this experiment let us infer their 
involvement in the reduction of inflammatory response around calving. 
Although milk yield was very similar, OPT cows showed a lower recourse to the 
body reserves of fat (BCS drop was 0.49 in OPT vs 0.63 in CTR, confirmed by the 
significantly lower NEFA levels, Figure 1) and protein (lower reduction of 
creatinine; Finco, 1997) in the first 6 weeks of lactation). This metabolic status 
suggests that CTR compared to OPT cows underwent a more severe risk of ketosis, 
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as proposed by Goff et al. (1997) when BHB exceeds 1.2 mmol/L, and, perhaps, of 
liver lipidosis (Bobe et al., 2004). CTR cows did not show any clinical ketosis (but 
more subclinical cases than OPT), but they mobilized more reserves with a similar 
milk yield and showed a less favorable metabolic status than OPT cows. In OPT, 
both the higher intake of ω3 FA and perhaps the slightly higher intake of total 
energy (due to the supplement or to an higher feed consumption) may have 
contributed to improve the metabolic status. 
Finally, among the other parameters assessed in plasma, tocopherol is an 
interesting index involved in oxidative processes and enhancement of mastitis 
resistance (Sordillo et al., 2009). Its trend in OPT did not show a drop before 
calving, marking a difference from CTR group which showed the usual reduction 
around calving (Goff et al., 1990; Bionaz et al., 2007). This is likely justified by its 
abundant presence in the formula of the administered supplement (which have 
increased by 1.5 folds the daily intake in dry and by 3 folds in lactation period). 
Tocopherol is used as antioxidant to protect ω3 FA from peroxidation during the 
storage of Optimate; thus, a relevant amount of this vitamin may be also absorbed 
in the gut as confirmed by our data. Tocopherol exerts its protective action on ω3 
FA until they are incorporated in tissues (Scislowski et al., 2005) and, in addition, can 
contribute to the reduction of pro-inflammatory cytokines synthesis, as shown by 
van Tits et al. (2000). Nevertheless, the reduction of tocopherol observed after 
calving in both groups may be explained by a lower synthesis of carrier proteins (e. 
g. lipoproteins) in response or in relationship with the inflammation also observed 
in both groups. The good correlation between cholesterol and tocopherol (r=0.62) 
confirm this possibility. The shorter and less severe inflammation observed in OPT 
may be partly justified by the higher availability of vitamin E, but the less severe 
inflammation due to ω3 may have also contributed to the quicker recovery of 
lipoproteins and plasma vitamin E itself. 
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CONCLUSIONS 
The supplementation of algae-derived ω3 FA contained in Optimate caused an 
increase in the body availability of ω3 FA (in particular the index ω3 HUFA on total 
HUFA) and vitamin E, particularly before calving. Furthermore, the inflammatory 
situation was similar between groups, as shown by the +APP levels in early post-
calving. Nevertheless, the body response was less severe in OPT, which showed a 
significant quicker recovery of –APP to normal values, the latter well summarized in 
the Liver Functionality Index. Besides the higher levels of plasma ω3 FA, also 
vitamin E levels may explain the reduced inflammatory response of OPT group. 
From the practical point of view, this kind of ω3 supplementation in the transition 
period leads to a different inflammatory condition that could justify a lower 
lipomobilization, which implies a lower ketosis risk, maintaining a similar milk yield. 
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COMPONENTS [% of DM] Close-up dry cows Lactating  Cows
Grass hay 49.63 7.37
Alfalfa hay - 11.64
Wheat straw 16.50 -
Corn silage 25.60 32.90
Corn meal (67%) and corn flakes (34%) - 24.85
Cottonseed - 8.68
Soybean meal and mineral and 
vitamin supplementation
8.30 -
Commercial concentrate - 14.56
DMI [kg/d] 12.50 23.62
CHEMICAL COMPOSITION
NEL [Mcal/kg of DM] 1.29 1.58
CP [% of DM] 12.44 16.11
NDF [% of DM] 56.57 33.88
Starch + sugar [% of DM] 12.58 26.83
Ether extract [% of DM] 1.91 4.79
Table 1 - Nutritional value of the diets fed as TMR for close-up and lactating
cows
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FATTY ACID % mg/100 g g/cow/d
Total saturated 34.09 12896.64 38.35
Total monousaturated 39.01 14712.22 43.89
18:2 ω-6 4.64 1755.93 1.81
20:3 ω-6 0.10 38.53 0.04
20:4 ω-6 (ARA) 0.45 169.46 0.18
22:5 ω-6 0.16 59.55 0.06
others 0.48 184.35 0.19
Total ω-6 PUFA 5.83 2207.82 2.27
18:3 ω-3 1.21 456.72 1.36
20:5 ω-3 6.74 2548.94 7.58
22:5 ω-3 2.42 916.06 2.72
22:6 ω-3 6.67 2524.85 7.50
others 2.56 968.60 2.88
Total ω-3 PUFA 19.60 7415.17 22.05
Others 1.45 550.42 1.63
OVERALL TOTAL 100.00 37782.27 112.48
Table 2 - Detailed fatty acids composition (percentage of the total fat and mg/100 g) of
ω3 supplement (Optimate, Agritech, Tipperary, Ireland) and daily amount of each fatty
acid received by each treated cow with the supplement. The total daily intake of fat
supplement was 112.5 g/cow and included non-lipophilic compounds of fat molecules
(e.g. glycerol, choline, sphyngosine).
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Fatty acid group -21 -3 21 42
OPT 0.72 1.08 0.71 0.49
CTR 0.71 0.53 0.78 0.58
P NS <0,01 NS NS
OPT 0.10 0.30 0.31 0.12
CTR 0.08 0.08 0.06 0.05
P NS <0,001 <0,001 <0,1
OPT 0.67 0.65 0.74 0.53
CTR 0.63 0.53 0.52 0.53
P NS NS <0,05 NS
OPT 90.78 73.72 80.88 106.33
CTR 54.39 60.65 56.12 82.76
P <0,05 NS NS NS
ALA [µg/mL]
Table 3 - Main plasma fatty acids variations (as percentage of total fatty acids) in periparturient cows
fed (OPT, n=3) or not (CTR, n=3) with 22 g/d of ω3 during the three weeks before and after calving
assessed at -21 (pre- ω3 treatment); -3 (prepartum); +21 (ω3 treatment end) and +42 (after ω3
treatment) DIM. Data are expressed as % of total fatty acids Statistically significant differences are
marked as +P<0.10; *P<0.05; **P<0.01; ***P<0.001.
EPA [%]
DHA [%]
DPA [%]
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Figure 2 - Cholesterol and haptoglobin plasma levels (mean ± SD) in periparturient cows fed (n=6,
continuous line) or not (n=6, dotted line) with 22 g/d of ω3 during the three weeks before and after
calving. Statistically significant differences are marked as +P<0.10; *P<0.05; **P<0.01; ***P<0.001.
Figure 1 - Glucose and NEFA plasma levels (mean ± SD) in periparturient cows fed (n=6,
continuous line) or not (n=6, dotted line) with 22 g/d of ω3 during the three weeks before and after
calving. Statistically significant differences are marked as + P<0.10; *P<0.05; **P<0.01; ***P<0.001.
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Figure 3 - Albumins and tocopherol plasma levels (mean ± SD) in periparturient cows fed (n=6,
continuous line) or not (n=6, dotted line) with 22 g/d of ω3 during the three weeks before and after
calving. Statistically significant differences are marked as +P<0.10; *P<0.05; **P<0.01; ***P<0.001
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Figure 4 - EPA and DHA plasma levels (as % of total fatty acids) in periparturient cows fed
(n=3, continuous line) or not (n=3, dotted line) with 22 g/d of ω3 during the three weeks
before and after calving. Statistically significant differences are marked as +P<0.10; *P<0.05;
**P<0.01; ***P<0.001.
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INTRODUCTION AND AIM 
The ω3 fatty acids (FA) are told to be effective in the modulation of 
inflammation, as these essential fatty acids are key molecules in the metabolism of 
eicosanoids, mediators of inflammation (Calder, 2006; Mori and Beilin, 2004; 
Teitelbaum, 2001). The mechanism involves the cyclooxygenase enzymes (COX), 
which initiate a cascade converting arachidonic acid (ω6 fatty acid) in a number of 
molecules called eicosanoids which exert different actions in the inflammatory 
process. A prolonged administration of ω3 FA cause their accumulation in tissues 
(von Schacky et al., 1985) and this allows later their replacement for the arachidonic 
acid, causing the production of less pro-inflammatory eicosanoids (3-serie 
prostaglandins and thromboxane; Mori and Beilin, 2004), or other molecules 
involved in the resolution phase of inflammation (resolvins and protectins; Serhan 
and Savill, 2005). Interestingly, Groeger et al. (2010) demonstrated the formation of 
electrophilic oxo-derivatives (EFOX) from eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA) through COX-2 in activated macrophages, enhanced 
with the modulation of this pathway by acetylsalicylic acid. These compounds have 
anti-inflammatory effect exerted through an agonist action on the gene expression 
of the peroxisome proliferator-activated receptor-γ (PPARγ) and through the 
inhibition of pro-inflammatory cytokine and nitric oxide production. Acetylsalicylic 
acid is widely used in case of acute inflammation for its potent anti-inflammatory 
effect exerted through the inhibition of both cyclooxygenase 1 and 2 (Vane, 2003). 
This action is also effective at low dose in murine models (Cyrus, 2002) and is useful 
to prevent inflammation in patients affected by cardio vascular diseases (Patrono et 
al., 2005). 
There are some evidences in human that a synergic action of ω3 FA and 
acetylsalicylic acid at low dose may be exploited to control and to reduce the 
production of pro-inflammatory eicosanoids (Engström et al., 2001). In the past, we 
treated cows with acetylsalicylic acid after calving with good results on milk yield, 
fertility and metabolic status (Trevisi and Bertoni, 2008). However, the effects of 
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non-therapeutic doses of acetylsalicylic acid joint to ω3 FA supplementation on 
livestock was not investigated before. In particular, we are not aware of experiments 
in dairy cows based on the daily pre-calving administration of acetylsalicylic acid and 
ω3 FA. 
Thus, our aim was to assess the effects of the synergic action of ω3 FA and 
acetylsalicylic acid administered before calving to reinforce the natural systems of 
inflammation resolution in the transition period of dairy cows. 
MATERIALS AND METHODS 
This study complied with Italian and European rules on animal experimentation 
and ethics. 
BARN CHARACTERISTICS, ANIMALS AND TREATMENTS 
The trial took place in the Università Cattolica experimental barn (CERZOO) 
located in the Northern Italy (Piacenza) during autumn-winter season and involved 
26 multiparous Friesian dairy cows reared in loose stall with cubicles and milked 
twice a day (12 hours gap). Dry and lactating cows were fed with two different total 
mixed ration (TMR) diets described in Table 1. Three homogeneous groups were 
formed according to body condition, calving period, production potential, parity, 
mammary gland health, body weight. The first group received a combination of ω3 
fatty acids and acetylsalicylic acid (n = 9; OMAS): the fish-derived oil administration 
started about 21 days before calving and lasted through the day before calving. The 
dose administered was 100 g/cow/d of commercial product (Orovital Cod; Ascor 
Chimici Srl, Capocolle di Bertinoro, FC, Italy), corresponding to 75 g/cow/d of 
fatty acids. According to the composition of the product (Table 2), the cows 
received daily 12.0 g of ω3 fatty acids (among them 4.6 g of EPA and 6.0 g of 
DHA); ω6 fatty acids were administered with the product in the extent of 1.6 g/d. It 
was fed once a day immediately before the TMR distribution, and it was mixed with 
about 0.5 kg of fresh cows TMR. There was no possibility of competition among 
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cows to ingest the supplement. The last 7 days of pregnancy OMAS cows received 
also a daily intramuscular injection of lysine acetylsalicylate (Lysal, Farmaceutici 
Gellini Srl, Peschiera Borromeo, MI, Italy) in the extent of 0.036 mg/kg BW 
(corresponding to 6.0 mg/kg BW of acetylsalicylic acid). The second group (n = 9; 
OM) only received the same ω3 fatty acids supplement of OMAS group. The last 
group (n = 8; CTR) received, for the same period, an administration of palm oil (75 
g/d) to balance the energy intake of the other two groups (Greenfat 3G, Or Sell Srl, 
Limidi di Soliera, MO, Italy). The whole detailed FA composition of the product is 
described in Table 3. 
CLINICAL CHECKS 
During the experiment, animals health conditions were checked every day by 
general inspections and monitored by a computerized Afimilk system (S.A.E. 
Afikim, Kibbutz Afikim, Israel), based on automatic recording of activity and milk 
production through a leg transponder. In addition, rectal temperature was measured 
the day after calving and twice a week from 14 day before to 14 days after calving. 
Cows were also submitted to a thorough gynecological examination at about 10 and 
30 days in milk (DIM), or when required by a suspect of pathology. Moreover, each 
cow was submitted to the following assessments: 1) Body condition scoring, using a 
5-point scale (ADAS, 1986), starting about 35 d before the expected calving date 
and, then, every 14 days to 35 DIM. 2) Milk yield and its conductivity, measured and 
recorded by the Afimilk computer-controlled automated system at every milking. 3) 
Milk samples at 7, 14, 28 DIM, from the morning milking, in order to assess fat, 
protein and lactose content (MilkoScan FT 120, Foss Electric, Hillerød, Denmark), 
and somatic cell count (SCC; Fossomatic 180, Foss Electric). 4) Blood samples, 
collected approximately (±3 days) at -28, -21 (pre-treatment), -14, -10, -7, -3 (before 
calving), 1 (day after calving), 3, 7, 10, 14, 21, 28, 35 (post-treatment) days from 
calving. Every sample was collected in the morning before feeding, from a jugular 
vein and in two vacuum tubes (Vacuette, Greiner Bio-One GmbH, Kremsmunster, 
Austria), one containing lithium-heparin as anticoagulant, and the other silicon (no 
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anticoagulant). Lithium-heparin tubes were cooled immediately after collection in an 
ice-water bath until their arrival in laboratory. After a small aliquot of blood was 
taken to determine packed cell volume (centrifugation at 12000 RPM for 11 
minutes), tubes were centrifuged at 3520 × g for 16 minutes at 4°C; plasma samples 
were divided in 5 aliquots, stored at -20°C (4) or -80°C (1). In accordance with the 
methods described in Bionaz et al. (2007) on these samples were determined: I) 
Inflammatory response indexes: positive acute phase proteins (+APP; haptoglobin, 
ceruloplasmin) and negative acute phase proteins (-APP; albumin, cholesterol as 
lipoprotein index). II) Liver indexes: total bilirubin, aspartate amino-tranferase 
(GOT), γ-glutamil transferase (GGT), alkaline phosphatase (ALP), paraoxonase 
(PON), activated paraoxonase, sorbitol dehydrogenase (SDH). III) Energy 
metabolism indexes: glucose, non-esterified fatty acids (NEFA), β-hydroxybutyrate 
(BHB). IV) Protein metabolism indexes: urea, creatinine. V) Oxidative stress and 
related parameters: total reactive oxygen metabolites (ROM), total nitric oxide 
metabolites (NOx), nitrites (NO2), nitrates (NO3), myeloperoxidase (MPO), thiol 
groups (SHp), total antioxidants. VI) Minerals (Ca, P, Mg, Na, K, Cl, Zn). VII) 
Vitamins: retinol (index of its carrier protein), tocopherol, β-carotene. VIII) Other 
parameters (total proteins, globulins). 
Glucose, total protein, albumin, total cholesterol, total bilirubin, creatinine, urea, 
Ca, P, Mg, GOT, GGT and ALP were detected at 37°C by a clinical auto-analyzer 
(ILAB 600, Instrumentation Laboratory, Lexington, MA) using commercial kits 
purchased by Instrumentation Laboratory (IL Test), as previously described by 
Bionaz et al. (2007). Globulins were calculated as the difference between total 
protein and albumin. Electrolytes (Na+, K+, and Cl−) were detected by the 
potentiometer method (Ion Selective Electrode connected to ILAB 600). Zn and 
NEFA were determined by commercial kits (Wako Chemicals GmbH, Neuss, 
Germany). Haptoglobin, BHB, and ceruloplasmin were analyzed using methods 
described by Bertoni et al. (1998), adapted to ILAB 600 conditions. ROM were 
measured using a method patented by Diacron International S.r.l. (Grosseto, Italy) 
and expressed as mg of hydrogen peroxide per 100 mL of plasma. Plasma PON 
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activity was assessed by adapting the method of Ferré et al. (2002) to the ILAB 600, 
as described by Bionaz et al. (2007). The activated PON activity was determined 
with the same method, but the solution was composed by 1 mmol/L of paraoxon, 1 
mmol/L di CaCl2 and 1 mol/L di NaCl in a glycine buffer solution 0.05 mmol/L. 
The activity of MPO was determined through a colorimetric method based on the 
reaction of MPO contained in the plasma sample with the hydrogen peroxide, 
which forms H2O and O-. The O-dianisidine dihydrochloride, donor of electron, 
reacts with the O-, releasing H2O and a colored compound. Thiol groups are 
detected using a colorimetric method by Diacron International S.r.l. (Grosseto, 
Italy). The principle of the test is based on the formation of a colored complex, as a 
product of the reaction between sulfhydryl groups and the 5,5-ditiobis-2-
nitrobenzoic acid in a buffer solution (pH 7.6). The intensity of the color detected is 
directly related to the concentration of thiol groups. The concentration of nitric 
oxide can be assessed as a sum of nitrites (NO2-) and nitrates (NO3-). The assay 
procedure is composed by two steps: enzymatic reduction of NO3- to NO2- 
(manual; nitrate reductase) and the determination of the NO2- (automatic). The 
enzymatic reduction is an end-point reaction lasting about 3 hours in water bath at 
37°C between a reducing solution and the sample. After the enzymatic reduction, 
the total NO2- are detected (NO2- + NO3-), which correspond to the NOx. The 
determination is colorimetric (Griess test). The analysis is a spectrophotometric 
measure at 546 nm of a colored complex derived from the reaction between NO2- 
and a cromogen (naphthyl-etylen-diamine), properly buffered. The detection of the 
only NO2 consists in the automatic analysis, without the preliminary enzymatic 
reduction and a with a difference in the calibration. The determination of SDH was 
carried out on serum samples through a kit provided by Catachem Inc. (Bridgeport, 
CT, USA, enzymatic test). The test is based on the reversible oxidation-reduction 
reaction between sorbitol and fructose, catalyzed by SDH, with concomitant 
oxidation of NADH to NAD+. The absorbance decrease is monitored at 340 nm 
and is directly proportional to SDH activity in serum samples. 
The working conditions of ILAB600 are summarized in appendix 2. 
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Plasma retinol, tocopherol and β-carotene were extracted with hexane and 
analyzed by reverse-phase HPLC using Spherisorb ODS-2.3 µm, in a 150 × 4.6 mm 
column (Alltech, Deerfield, IL); a UV detector set at 325 nm (for retinol) or 290 nm 
(for tocopherol); and 80:20 methanol:tetrahydrofurane as the mobile phase. Total 
antioxidants were determined through the oxygen radical absorbance capacity 
(ORAC) assay, which is based on the free radical damage to a fluorescent probe 
(fluorescein), resulting in a downward change of radical damage. This analysis was 
performed with a multi-detection microplate reader equipped with a dual reagent 
injector and with a software for kinetic data collection and analysis (BioTek Synergy 
2, Winooski, VT, USA). 
DATA HANDLING AND STATISTICAL ANALYSIS 
All data in this paper are presented in the form mean ± standard deviation. 
Repeated measures analysis of variance. Data were submitted to repeated measures 
variance analysis using a mixed model (MIXED procedure, SAS Inst. Inc., Cary, 
NC; Littell et al., 1998). Before analysis the normality of distribution was verified for 
each parameter through skewness and kurtosis calculation according to the Shapiro 
test (SAS Inst. Inc.). When necessary, data were normalized through logarithmic, 
quadratic, inverse or root-square transformations. The layout of our statistical model 
can be summarized as follows: 
Yiklm = μ + Gi + Tk + GTik + Bl(im) + eiklmn 
where Yijklm = mth observation of the lth cow Bl within the ith treatment Gi, at the kth 
time to calving Tk; μ = total average; Gi = effect of the ith treatment (3 treatments: 
OM, OMAS and CTR); Tk = effect of the kth time to calving (the number of levels 
being defined as a function of pregnancy phase and actual variable); GTik = effect of 
the interaction between the ith treatment and the kth time to calving; Bl(im) = effect of 
the lth cow within the ith treatment; eiklmn = random effect or error. 
The analysis was carried out using 3 covariance structures: Autoregressive, 
Compound symmetry, and Spatial Power. These were ranked according to their AIC 
(Akaike’s Information Criterion; Akaike, 1974), choosing as better the lowest one 
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(Littell et al., 1998). For each treatment, least squares means were computed, and 
preplanned pairwise comparisons (PDIFF option, SAS Inst. Inc.) were carried out 
when the F-test of one of the main factors (time, treatment, treatment × time) was 
significant at P<0.10. Statistical significance was designated as P<0.05, tendencies 
were declared at P<0.10. 
One-way variance analysis. The differences among groups of some parameters 
(pregnancy length, number of artificial inseminations, days open) were statistically 
evaluated through a one-way analysis of variance (GLM procedure, SAS Inst. Inc., 
Cary, NC) considering as a fixed factor the group. The layout of our statistical 
model can be summarized as follows: 
Yij = μ+ Gi + eij 
where: Yij = ith observation of the group with jth parameter; μ = total average; Gi = 
effect of the ith value (i = group); eij = random effect or error. 
PIRI index application. Cows were divided in tertiles based on their score ofPost-
calving Inflammatory Response Index (PIRI), described in detail in the first chapter 
of this thesis: high PIRI (HI-PIRI), intermediate PIRI (IN-PIRI) and low PIRI (LO-
PIRI). This index combines the plasma concentrations of cholesterol, haptoglobin, 
paraoxonase and reactive oxygen metabolites assayed 7 days after calving, in order 
to give an idea of the inflammatory status and of the inflammatory response that 
affect the cow in the immediate post-calving. The cows falling in the lowest tertile 
are characterized by an important inflammatory status at calving and by an 
inadequate response, while in the highest tertile are gathered the cows that suffered 
a mild inflammation (HI-PIRI). Among the three tertiles were carried out the same 
model of statistical analysis already performed among the groups of treatment 
(repeated measures and one-way variance analysis). 
Χ2 test was carried out to assess a possible association between inflammation 
(expressed by PIRI index) and treatment. 
FSI index application. The Fertility Status Index was calculated for each group 
according to Esslemont and Eddy (1977). This index is calculated for a group of 
cows and takes into account the number of pregnant cows on the total cows, the 
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pregnant cows at 1st AI, the average number of AI per pregnancy and the average 
days open. 
RESULTS 
A) EFFECTS OF Ω3 FA AND ACETYLSALICYLIC ACID TREATMENTS 
The planned days of supplement administration slightly differed because of the 
calving date variability. OM group received ω3 FA for 19±5 days, while OMAS 
cows for 25±5. The OMAS group received acetylsalicylic acid for 8±2 days and the 
CTR group received the administration of saturated fatty acids for 22±7 days. 
The length of pregnancy was evaluated: OM cows calved in advance in respect to 
the other groups (277±6 days of pregnancy); CTR groups calved in 281±6 days of 
pregnancy, while OMAS calved after 284±5 days of pregnancy. The difference 
between OM and OMAS in days of pregnancy turned out statistically significant 
(P<0.02). 
Animal health 
Most of the cows involved in the experiment did not show any disease during 
their transition period. Some of them were affected by mild troubles which did not 
require any kind of intervention (e.g. one-day high temperature or diarrhea). 
However, some cows were affected by severe pathologies immediately after calving 
(Table 5). In CTR group two cows showed lameness and metritis. In OM group one 
only cow was affected by retained placenta and one by diarrhea. In OMAS group 
three cows suffered several problems: one retained placenta, one severe ketosis and 
one both retained placenta and ketosis. The cows that suffered retained placenta 
were treated with oxytetracyclin Tablets in uterus, and in one case with serotonin + 
ergometrine and an anti-inflammatory drug. Cows with severe ketosis were 
administered glucose in jugular vein for 2-3 days according to the severity of the 
pathology. 
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Rectal temperature trend did not show any statistical difference among groups. 
However, a numerically lower temperature (0.2°C) has been found between OMAS 
and the other two groups 3 days before calving (38.83±0.18 in OMAS, 39.03±0.14 
in OM, 39.02±0.32 in CTR). The reported cases of fever showed temperatures 
higher than 39.5°C for more days. Episodic temperatures >39.5°C without any 
other clinical symptom are not reported here as fever cases. 
BCS (Figure 2) showed in all the three groups the typical post-calving drop: it 
started a week before calving and kept on through all the checked period. OM 
group showed a tendency to have a smaller decrease of BCS compared to CTR: 
0.33±0.19 vs 0.57±0.27 points of body condition from 7 days before calving to 35 
DIM; P<0.10. OMAS group lost 0.51±0.27 points. 
Performances 
Milk yield and quality. Milk yield (Figure 1) was not statistically different among 
groups: CTR cows produced 1158±100 kg in the first 28 DIM, while OM gave 
1115±258 and OMAS 1075±115 kg. The assessed parameters of milk quality did 
not show any statistical difference. 
Fertility. Five cows were culled due to infertility during the lactation following the 
experiment: 1 in CTR, 1 in OM and 3 in OMAS groups. CTR cows showed an 
overall better reproductive performance than the other two groups (Table 7): days 
open were 95±46 and the number of inseminations was 1.7±1.1. For OM cows the 
days open were 120±47 and the number of inseminations was 2.3±1.2. The OMAS 
group was characterized by the worst values: 158±55 days open and 3.3±1.5 
inseminations. The differences between CTR and OMAS were significant for days 
open (P<0.03) and for number of inseminations (P<0.03). 
The values of FSI index confirmed an optimal situation in CTR (83.9), good in 
OM (44.5) and bad in OMAS (-4.5). 
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Blood parameters 
Energy metabolism. Glucose (Figure 4) showed in all groups a peak after calving 
followed by a drop in the following days. However the glycaemia in OM group 
recovered pre-calving levels before than the other groups, and at 7 DIM was higher 
than in the other groups (4.07±0.43 mmol/L in OM, 3.42±0.95 mmol/L in OMAS 
and 3.52±0.46 mmol/L in CTR; P<0.001 OM vs OMAS and P<0.01 OM vs CTR). 
BHB trend (Figure 12) displayed post calving a high peak in OMAS at 7 DIM 
(1.63±1.58 mmol/L). In OM and CTR groups the peak occurred at 1 (0.81±0.27 
mmol/L) and 3 DIM (0.89±0.62 mmol/L). At 7 DIM, BHB level was higher in 
OMAS than in the other two groups (P<0.01 vs OM and P<0.05 vs CTR). At 10 
DIM OMAS group tended to maintain higher levels of BHB than OM (0.53±0.14 
mmol/L in OM vs 1.02±0.92 mmol/L in OMAS; P<0.10) and CTR (NS), while a 
tendency to be lower was detected in OM vs CTR (0.44±0.10 vs 0.68±0.33 mmol/L 
at 21 DIM; P<0.10). NEFA levels (Figure 11) were characterized by similar trends, 
with higher levels in OMAS and lower in OM after calving, but not confirmed by 
statistics. The peak occurred in OMAS at 7 DIM (0.98±0.50 mmol/L), while it was 
reached at 3 DIM in OM (0.68±0.42 mmol/L) and CTR (0.73±0.44 mmol/L). 
Inflammatory status. Haptoglobin (Figure 10) maintained low values (<0.2 g/L) in 
all the three groups until 7 days before calving. Three days before calving it started 
to increase in OMAS group and reached a peak at 7 DIM (1.17±0.90 g/L in OMAS; 
0.29±0.30 g/L in CTR, 0.40±0.34 g/L in OM P<0.01 CTR vs OMAS and P<0.05 
OM vs OMAS). The difference continued to be significant between CTR and 
OMAS at 10 and 14 DIM (P<0.05). CTR and OM groups reached the peak already 
at 3 DIM (0.49±0.43 g/L in CTR, 0.70±0.38 g/L in OM), and after decreased. At 
21 DIM the levels were similar among the three groups. 
Cholesterol (as index of lipoprotein, Figure 5) had a significantly higher level 
already at the beginning of the experiment in OM than in the other two groups 
(3.55±0.71 mmol/L in OM, 2.79±0.79 mmol/L in CTR and 2.69±0.41 mmol/L in 
OMAS 28 days before calving; P<0.01 vs CTR and OMAS). Cholesterol confirmed 
significantly higher levels in OM for the whole period of the experiment. The level 
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in OMAS, similar to CTR 28 days before calving, decreased more markedly and 
reached the greatest difference at 1 DIM (1.95±0.46 mmol/L in OMAS, 1.70±0.34 
mmol/L in CTR; NS). Later, OMAS showed an increasing trend less marked than 
CTR, and the values tended to be lower at 10 DIM (2.03±0.65 mmol/L in OMAS, 
2.36±0.44 mmol/L in CTR; P<0.10). 
Albumin levels (Figure 6) were similar before calving, while after calving the 
increase resulted delayed in OMAS vs CTR and OM (34.58±3.17 g/L in OMAS, 
36.86±2.57 g/L in CTR, 36.58±1.79 g/L in OM; P<0.01 OMAS vs OM and CTR at 
10 DIM). 
Retinol (as index of retinol binding protein, Figure 14) plasma level decreased 
approaching calving in all the groups. After calving, it showed a quick raise in CTR 
and OM, while in OMAS it was slower. The greatest differences were reached at 10 
DIM (33.79±19.63 µg/100 mL in OMAS, 47.31±15.22 µg/100 mL in OM, 
51.56±19.98 µg/100 mL in CTR; P<0.01 OMAS vs CTR and P<0.05 OMAS vs 
OM). Later the differences decreased and at 21 DIM the levels were similar. 
Paraoxonase plasma levels (Figure 13) were slightly lower in OMAS before 
calving in respect to OM and CTR (NS). After calving this difference increased and 
at 14 DIM paraoxonase concentrations were 124.23±24.72 U/mL in CTR, 
126.43±26.18 U/ mL in OM and 94.22±28.85 U/ mL in OMAS; P<0.05 OMAS vs 
CTR and P<0.01 OMAS vs OM. 
Bilirubin (whose clearance enzymes are synthesized by the liver, Figure 8) plasma 
trend showed an overall increasing trend in late pregnancy, reaching a peak 3 days 
after calving in all groups (6.72±2.62 mmol/L in CTR, 6.61±3.68 mmol/L in OM 
and 7.61±4.99 mmol/L in OMAS) and a decrease in the following 3 weeks after 
calving. Despite no significant differences were found, OMAS showed higher values 
in comparison to OPT and CTR. 
Other parameters. GGT plasma level (FigureFigure 7) showed lower values in 
OMAS than in the other experimental groups (19.02±3.37 U/L in OMAS vs 
26.91±6.61 U/L in CTR; P<0.01) already 28 days before calving. The difference 
was significant until 7 DIM, then levels were similar. ALP (Figure 9) showed in 
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OMAS group a numerically lower level in late pregnancy than in CTR and OM and 
peaked in both groups the day after calving (54.44±27.80 U/L in OMAS vs 
60.01±23.13 U/L in CTR; NS). SDH (Figure 15) had a similar trend, keeping lower 
levels in OMAS from 28 days before calving to 14 DIM. The day after calving levels 
were 8.23±1.92 U/L in OMAS and 11.43±5.01 U/L in CTR. 
B) DIFFERENCES AFTER DIVISION OF COWS ACCORDING TO THE 
PIRI INDEX 
In order to assess the frequency of severe inflammatory conditions around 
calving in different treatments, cows were assigned a score of PIRI index and later 
divided in tertiles according to these values (Table 4). Data will be shown and 
discussed mainly comparing the two extreme tertiles (high, HI-PIRI and low, LO-
PIRI), while the intermediate tertile (IN-PIRI) will be mentioned only in case it 
shows particularly interesting values. Furthermore, only important and interesting 
parameters will be reported in the text. 
Animal health 
As a result of PIRI index application, cows which suffered most of the health 
problems have been gathered in the lowest tertile (Table 6). No health diseases can 
be found in the highest tertile and in the intermediate except one case of diarrhea. 
Rectal temperatures did not show any significant difference among the tertiles. 
The body condition of the cows in the lowest tertile was significantly higher than 
the other two tertiles 35 days before calving (2.74±0.35 points in LO-PIRI vs 
2.48±0.21 points in HI-PIRI; P<0.05; Figure 17). The difference remained 
significant until calving, but later it thinned because of the greater reduction in LO-
PIRI: body condition loss from 14 days before calving to 35 DIM was 0.34±0.12 
points in HI-PIRI vs 0.56±0.32 in LO-PIRI. 
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Performances 
Milk yield and quality. Milk yield (Figure 16) was significantly different between HI-
PIRI and LO-PIRI. The total average production in the first 35 days of lactation 
was 1530±231 kg in HI-PIRI vs 1314±193 kg in LO-PIRI (P<0.01). Somatic cell 
count was higher in LO-PIRI at 14 DIM (283±251 n/µL in LO-PIRI vs 95±105 
n/µL in HI-PIRI P<0.05). 
Fertility. HI-PIRI cows showed a shorter period of days open (Table 8): 
101.3±45.9 vs 147.2±49.8 in LO-PIRI (N.S.). The number of inseminations was 
2.0±1.2 in HI-PIRI vs 3.0±1.5 in LO-PIRI (NS). 
The values of FSI index were 71.3 in HI-PIRI, 52.0 in IN-PIRI and -4.3 in LO-
PIRI. 
Blood parameters 
Energy metabolism. Glucose (Figure 19), similar before calving, showed a higher 
peak in LO-PIRI at 1 DIM (P<0.01 vs HI-PIRI), while in the following days it 
greatly decreased in the same group and at 7 DIM it was significantly lower 
(3.26±1.04 mmol/L in LO-PIRI vs 3.89±0.26 mmol/L in HI-PIRI; P<0.001). In 
the following controlled period it partly recovered its level, but it remained 
numerically lower than in the other tertiles. 
NEFA levels (Figure 28) were similar until 7 days before calving. Three days 
before calving they tended to be higher in LO-PIRI and the difference remained 
higher for the first 10 DIM, peaking at 7 DIM in LO-PIRI (1.04±0.51 mmol/L vs 
0.45±0.17 in HI-PIRI; P<0.001). 
BHB (Figure 29) peaked at 1 DIM in HI-PIRI, while in LO-PIRI it peaked at 7 
DIM maintaining significantly higher levels from 3 to 10 DIM (at 7 DIM levels were 
1.85±1.56 mmol/L in LO-PIRI vs 0.52±0.18 mmol/L in HI-PIRI; P<0.001). 
Creatinine (Figure 30) showed in LO-PIRI increasing level during pregnancy and 
through the first day after calving (at 1 DIM levels were 116.42±13.73 mmol/L in 
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LO-PIRI and 104.09±4.68 mmol/L in HI-PIRI; P<0.01). From 3 DIM no 
differences were shown and the trends were decreasing. 
Inflammatory status. Among the +APP, plasma concentration of haptoglobin 
(Figure 27) started increase three days before calving and achieved a peak in HI-
PIRI at 3 DIM. In LO-PIRI peaked at 7 DIM with the highest values (1.31±0.78 
g/L in LO-PIRI vs 0.22±0.12 g/L in HI-PIRI; P<0.001). Ceruloplasmin (Figure 22) 
showed a tendency to be higher in LO-PIRI 3 days before calving. At 3 DIM 
ceruloplasmin peaked in LO-PIRI and confirmed the tendency to be higher in this 
group (3.95±0.48 µmol/L in LO-PIRI vs 3.43±0.35 µmol/L in HI-PIRI; P<0.10). 
However, IN-PIRI tertile showed the highest values of ceruloplasmin already during 
pregnancy: 21 days before calving its plasma concentration was 3.53±0.62 µmol/L 
in IN-PIRI vs 2.89±0.58 µmol/L in HI-PIRI (P<0.05). After calving the difference 
was greater (4.18±0.48 µmol/L in IN-PIRI vs 3.37±0.50 µmol/L in HI-PIRI; 
P<0.01 at 14 DIM).  
Among the –APP, albumin plasma concentration (Figure 23) was similar before 
calving and through the first 3 DIM. Starting at 7 DIM the albumin concentration in 
HI-PIRI increased, while in LO-PIRI decreased creating a marked gap which 
persisted until 21 DIM (P<0.001). The maximum difference was found at 10 DIM 
(37.62±2.03 g/L in HI-PIRI vs 33.46±2.10 g/L in LO-PIRI; P<0.001). Cholesterol 
(Figure 20) basal level at -28 DIM was higher in HI-PIRI than in LO-PIRI 
(3.74±0.55 mmol/L in HI-PIRI vs 2.60±0.60 mmol/L in LO-PIRI; P<0.001). 
Later, the difference decreased and was not significant from -3 to +3 days from 
calving. During lactation, cholesterol plasma concentration increased more quickly 
in HI-PIRI, and was higher in HI-PIRI from 7 to 35 DIM (P<0.001). The greatest 
difference was recorded at 35 DIM (5.23±0.77 mmol/L in HI-PIRI vs 3.81±0.70 
mmol/L in LO-PIRI; P<0.001). Retinol (Figure 32) followed a similar trend: in HI-
PIRI it was higher already during pregnancy (56.21±11.82 µg/100 mL in HI-PIRI 
vs 45.13±9.59 µg/100 mL in LO-PIRI; P<0.05 14 days before calving). After 
calving the difference was wider (51.65±16.12 µg/100 mL in HI-PIRI vs 
23.52±13.84 µg/100 mL in LO-PIRI; P<0.001 at 7 DIM) and retinol level was 
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significantly higher in HI-PIRI until 35 DIM. The plasma concentration of 
paraoxonase (Figure 31) was significantly higher in HI-PIRI vs LO-PIRI for all the 
experiment period, with the wider difference at 10 DIM (146.85±17.45 U/mL in 
HI-PIRI vs 72.15±17.02 U/mL in LO-PIRI; P<0.001). 
Bilirubin plasma concentration (Figure 26) did not show any important difference 
among tertiles before calving. It was characterized by a general marked increasing 
trend starting from 7 days before calving and peaked in both HI-PIRI and LO-PIRI 
tertiles the day after calving (5.78±4.24 mmol/L in HI-PIRI vs 10.08±6.16 mmol/L 
in LO-PIRI; P<0.01). However, the peak of bilirubin was significantly higher and 
persistent in LO-PIRI until 10 DIM (P<0.01 from 1 to 10 DIM vs HI-PIRI). 
Other parameters. Urea plasma levels (Figure 21) were higher in HI-PIRI after 
calving than in LO-PIRI (4.01±0.60 U/mL vs 2.98±0.61 U/mL; P<0.05 at 14 
DIM). Transaminases (GOT and GGT; Figures 24 and 25) showed similar levels 
between HI-PIRI and LO-PIRI before calving, while after that markedly increased 
in LO-PIRI. GOT turned out significantly higher at 10 and 14 DIM (118.73±32.57 
U/L in LO-PIRI vs 97.76±14.82 U/L in HI-PIRI; P<0.05 at 10 DIM), and GGT at 
14 and 21 DIM (37.93±11.60 U/L in LO-PIRI vs 25.57±5.90 U/L in HI-PIRI; 
P<0.05 at 21 DIM). 
DISCUSSION 
EFFECT OF THE Ω3 FA ADMINISTRATION ALONE OR IN 
COMBINATION WITH ACETYLSALICYLIC ACID 
Energy metabolism. In spite of a similar milk yield, the administration of ω3 FA 
(OM) may have caused some positive effects on energy metabolism in respect to 
CTR cows which received palm oil, as suggested by the smaller drop of BCS in OM. 
The lower lipomobilization in OM cows is confirmed by the significantly lower level 
of BHB (Figure 12) and numerically lower levels of NEFA (Figure 11) compared to 
CTR and to OMAS cows. This in turn agrees with the level of plasma glucose after 
calving, resulted higher in OM than in the two other groups. The better energy 
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status is likely due to a higher level of DMI in OM cows (not directly measured). 
Our previous work (second chapter of the thesis) and data of Ballou et al. (2009) 
confirm the better post-calving energy metabolism in cows fed a diet enriched in ω3 
FA. Conversely, Mattos et al. (2004), found lower plasma concentrations of glucose 
and higher of BHB in cows fed ω3 FA, while no differences were shown in NEFA 
vs cows fed olive oil. However, in this last trial, fish oil was administered in a large 
amount, which likely caused a strong reduction in DMI and several other problems 
reported by the authors. 
Inflammatory status and response to inflammation. Several works describe 
improvements in metabolism and inflammatory status after the administration of ω3 
FA in human (Calder, 2006; Clària et al., 2011; Mori and Beilin, 2004; Teitelbaum, 
2001). At the same time it is well known the action of acetylsalicylic acid during 
inflammation, either in human and in livestock (Vane, 1971). Trevisi and Bertoni 
(2008) administered acetylsalicylic acid to dairy cows in the post-calving, showing 
positive effects on milk yield, fertility, health condition and inflammatory status. 
Serhan et al. (2002) demonstrated in murine models the effectiveness of the 
combination of low dose acetylsalicylic acid and ω3 FA in the inflammation 
resolution through the production of resolvins. In humans the combination of ω3 
FA and acetylsalicylic acid was previously tested with some improvements in the 
eicosanoid pattern reducing the production of the pro-inflammatory types 
(Engström et al., 2001), but with some negative effects on bleeding time (Mueller et 
al., 1991; Larson et al., 2008). We are not aware of experiments based on the pre-
calving daily administration of acetylsalicylic acid in dairy cows. 
Our aim was to verify the possible synergic action of ω3 FA together with a low 
dose of acetylsalicylic acid to reinforce the natural systems of inflammation 
resolution in the last days of pregnancy of dairy cows, when important inflammatory 
processes are shown to take place (Bionaz et al., 2007; Trevisi, et al., 2009). Data 
concerning the inflammatory status show that all the groups underwent an 
inflammatory condition around calving, as demonstrated by the raise of positive 
acute phase proteins (e.g. haptoglobin; Figure 10) and in agreement with Bertoni et 
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al. (2008) and Trevisi et al. (2010). However, the levels of haptoglobin show a more 
critical situation in the OMAS group cows, in fact the post-calving increase was 
significantly higher than in CTR and in OM. Furthermore, the trends of –APP 
support the possibility that all OMAS cows (with or without clinical symptoms) 
suffered more severe and prolonged negative consequences to inflammation in 
comparison to CTR cows; indeed, the release from liver of the usual proteins (e.g. –
APP) resulted impaired in the first weeks of lactation, likely due to the higher 
production of +APP. In detail, plasma cholesterol (index of lipoprotein synthesis; 
Figure 5) showed lower levels in OMAS than in CTR during the first month of 
lactation. Albumin and paraoxonase (Figures 6 and 13) showed similar trends 
between groups, but OMAS showed lower levels after calving due to a slower 
recovery from minimum values. Plasma retinol trend (as index of Retinol Binding 
Protein synthesis; Figure 14) was also characterized by a slower recovery in the 
OMAS group and kept significantly lower levels in respect to CTR in the first two 
weeks after calving. The trends of –APP in OM group were similar to CTR, but 
noteworthy is cholesterol, which showed higher levels than the other two groups for 
the whole period of the experiment. The severe negative consequences to 
inflammation in OMAS group cows could have been a contributory cause in the 
occurrence of the worse energy balance, the lower milk yield in the first month of 
lactation and the more negative reproductive indices. Further clues of a possible 
altered hepatic functionality are given by the lower plasma levels of GGT (P<0.01; 
Figure 7) as well as SDH (NS; Figure 15) and ALP (NS; Figure 9) observed in 
OMAS cows in comparison to CTR already before the treatment and thus also 
before calving. 
The marked inflammatory processes observed in OMAS groups are in agreement 
with the higher incidence of clinical diseases (33% of cows; Table 5), mainly RP and 
ketosis, and consequent drug treatments (33% of cows needed antibiotic and/or 
anti-inflammatory treatments in the first week of lactation). Therefore, it is 
interesting to point up as all cows of OMAS group recovered later than other 
groups a satisfactory metabolic and health status. Nevertheless, at the end of the 
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first month, OMAS cows reached a good milk yield (close to CTR cows) and did 
not show any further clinical health problem during their lactation assignable to the 
treatment. Also interesting is the peculiar pattern of changes of some –APP in the 
last weeks of pregnancy. In particular, in OMAS group, retinol, bilirubin, PON, 
tocopherol, β-carotene, SDH and GGT tended to be lower or to decrease some 
time before the beginning of inflammation (identified by the haptoglobin raise and 
by the zinc drop). This makes suspect that, for some unknown reason, the OMAS 
cows were more susceptible to inflammation regardless of the treatment. A possible 
cause could be the higher BCS, despite within normal values. 
Fertility. CTR cows showed optimal reproductive performance (101±46 days 
open and 2.0±1.2 AIs; Table 7) confirmed by the high level of FSI index (84 
points), better than the ideal level suggested by Esslemont and Eddy (1977) (80 
points). OM had acceptable values of days open (120±47 days) and number of 
artificial inseminations (2.3±1.2 AIs) with a FSI = 44 points, better than the average 
values found in the area (179 days open and 2.8 AIs; A.I.A., 2010). The cows of 
OMAS group showed the worst situation in this experiment (158±55 days open and 
3.3±1.5 AIs; FSI = -5 points), but anyway better than the area averages. Several 
works which deal with the post-calving administration of ω3 FA report 
improvements in fertility performances. Petit and Twagiramungu (2006) and Petit et 
al. (2002) showed an improvement in gestation rate of lactating dairy cows fed 
flaxseed (rich in linolenic acid) during lactation, partly attributed to a lower 
production of PGF2α. Positive effects on fertility may be attributed to a higher 
concentration of ω3 FA showed in endometrium after the oral administration of 
fish meal in non-lactating beef cows by Burns et al. (2003) and in lactating dairy 
cows by Heravi Moussavi et al. (2007). In our experiment, the ω3 FA administered 
pre-calving did not improve fertility in comparison with cows that received palm oil. 
However, the bad fertility performances found in OMAS group may be attributed 
to the more severe inflammatory status which suffered these cows (Bertoni et al., 
2009), partly regardless of the treatment. 
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Possible implications in prostaglandin metabolism. Results showed as OMAS cows 
suffered immediately after calving some issues related to the reproductive apparatus, 
since the group on average delayed the calving 3 of days in comparison to CTR 
cows and of 7 days in comparison to OM and the 25% of cows suffered retained 
placenta. It is reported that some problems related to parturition, uterus motility and 
fetal membranes expulsion may be related to the action of the acetylsalicylic acid. 
This molecule exerts an inhibitory effect on cyclooxygenases (Vane, 2003), causing 
also a decrease in the production of PGF2α, an important component of the 
prostaglandin family derived from arachidonic acid (Stahringer et al., 1999). In 
addition, the administration of ω3 FA causes their replacement in phospholipids for 
arachidonic acid (Simopoulos, 2008), contributing to reduce the production of 
prostaglandins (including PGF2α). Several researches demonstrated the relationship 
between a low plasma level of PGF2α and troubles in the operations related to labor 
and uterus motility. In particular, it was connected to RP (Chassagne and Barnouin, 
1992; Takagi et al., 2002) and uterine involution (Lindell et al., 1982; Thompson et 
al., 1987). Despite we did not determine the plasma level of PGF2α, it is possible to 
speculate their drop in OMAS group cows after the acetylsalicylic acid and ω3 FA 
administration in OMAS cows. This synergic effect may have been a contributory 
cause in the etiology of RP and much more in the higher frequency and severity of 
inflammation which has been suggested to have a role in the prolonged pregnancy 
noticed in OMAS group cows. 
IDENTIFICATION OF THE SUBJECTS AT RISK THROUGH A BLOOD 
PROFILE AT 7 DIM 
In the first chapter of this thesis we described how a combination of some 
plasma inflammatory indices (cholesterol, haptoglobin, paraoxonase and reactive 
oxygen metabolites) assayed at 7 DIM allows a good prediction of the coming 
performance of the cows (Post-calving Inflammatory Response Index, PIRI). Here 
we apply this index to this set of data with the aim to give a support to its 
effectiveness. 
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Basing on this index we divided cows in tertiles with the aim to compare cows 
with the best (higher tertile) and the worst (lower tertile) inflammatory status at 7 
DIM. In the Table 4 are reported the average values of PIRI for every group. Data 
of plasma parameters strongly confirm that the cows in the lowest tertile suffered a 
more severe inflammatory condition than the cows in the highest tertile. In 
particular LO-PIRI, in respect to HI-PIRI cows, had significantly higher levels of 
haptoglobin and ceruloplasmin (Figures 27 and 22) for the first week of lactation; 
on the contrary, –APP (cholesterol, albumin, paraoxonase, retinol; Figures 20, 6, 13, 
14) levels were contemporaneously reduced (and bilirubin increased; Figure 26). 
Furthermore, the recovery of satisfactory plasma levels was reached much later in 
LO-PIRI. This trend of delayed –APP recovery was already observed in cows with a 
more severe inflammatory status as highlighted by the LAI and LFI indices (Trevisi 
et al., 2011). This higher occurrence of inflammation is also confirmed by the lower 
milk yield in the first month of lactation, while surprisingly the energy metabolism 
was characterized by worse indices in LO-PIRI cows (lower glucose, higher NEFA 
and BHB; Figures 19, 28, 29) which make suppose a more negative energy balance 
than in HI-PIRI cows. 
Interestingly, Table 4 shows that the 67% of OMAS cows is gathered in the 
lowest tertile, confirming the more frequent occurrence of inflammatory problems 
in the cows of this group. On the contrary, the presence of the 55% of OM cows in 
the best tertile compared with 33% of CTR cows, makes guess that OM cows had a 
better health and inflammatory status. Chi-square test confirms the association 
(P<0.10) between the treatment and the level of inflammation (PIRI index). 
According to these results, PIRI seems to be a useful index to split cows – one 
week after calving – in “good” subjects (characterized by a good clinical and 
subclinical health status, by a better response to inflammation and by better 
performances) and in “bad” subjects. This could allow a prompt intervention on the 
subjects that suffer more issues in the immediate post-calving and seems to be more 
operable than LAI and LFI, which give a response only after the first month of 
lactation (Trevisi et al., 2011). Interestingly, one only blood sample is needed at 7 
124
  Chapter 3: Conclusion 
DIM, which makes easy the calculation of the index and so opens to the possibility 
of its field application. Furthermore, a possible application could be the attempt to 
improve as soon as possible the reproductive functionality that has been confirmed 
to be worse in LO-PIRI cows (FSI index = 6.2 in LO-PIRI vs 65.1 in HI-PIRI). 
CONCLUSION 
The attempt to attenuate inflammatory processes at calving through the use of 
low-dose NSAIDs in advance in combination with ω3 FA did not exert any positive 
effect. In fact, such a treatment caused a lengthening of pregnancy and an increase 
in the frequency of retained placenta. On the contrary, the results of this experiment 
confirm the usefulness of an ω3 FA administration in the peripartum period of dairy 
cows. The improvements are found in the slight reduction of inflammatory status 
after calving (higher frequency of cows treated with ω3 FA among cows with a low 
response to inflammation), and mainly in the energy metabolism immediately after 
calving, likely justified by a quicker raise of feed intake. 
After these results it is possible to suggest the administration of ω3 FA during the 
whole transition period (from three weeks before calving through three weeks after), 
while NSAIDs should be given only starting 24 hours after calving and in any case 
after the delivery of the placenta to avoid the interference in the prostaglandin 
metabolism, of major importance during these phases. 
The application of the Post-calving Inflammatory Response Index highlighted 
the possibility to treat in advance subjects that do not show any clinical health 
problem, but which likely would benefit from a support, since their subclinical 
problems may have later resulted in some troubles (liver and reproductive systems). 
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COMPONENTS [% of DM] Dry cows Lactating cows
Corn silage 25.0 33.5
Corn grain ground - 17.2
Alfalfa hay - 15.3
Soybean meal 7.3 9.2
Cottonseed - 7.7
Corn flakes - 7.4
Grass hay 51.6 3.5
Sunflower seed - 2.4
Mineral and vitamin supplementation
§ 1.0 2.1
Corn semolina glutinated - 1.7
Wheat straw 15.3 -
CHEMICAL COMPOSITION
NEL [Mcal/kg of DM] 1.4 1.5
CP [% of DM] 12.5 16.0
NDF [% of DM] 54.9 33.7
Starch + sugar [% of DM] 12.5 29.8
Ether extract [% of DM] 2.7 4.5
Water was added to each ration to reach the 52% of DM
§
42.9% Ca2PO4; 28.6% urea; 14.3% MgO; 7.1% NaCl; 7.1% mineral and
vitamin supplement (1500000 IU/kg vitamin A; 150000 IU/kg vitamin D;
7000 IU/kg vitamin E; 10 mg/kg Co; 70 mg/kg I; 1100 mg/kg Mn; 500
mg/kg Cu; 23 mg/kg Se; 4000 mg/kg Zn)
Table 1 - Nutritional value of the diets fed as TMR for close-up
and lactating cows
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g/d
C14:0 Myristic acid 3.06
C16:0 Palmitic acid 5.60
C16:1 ω-7 Palmitoleic acid 9.94
C18:0 Stearic acid 0.88
C18:1 ω-9 Oleic acid 11.34
C18:1 ω-7 Cis-vaccenic acid 3.14
C18:2 ω-6 Linoleic acid 1.05
C18:3 ω-3 Linolenic acid 0.37
C18:4 ω-3 Stearidonic acid 1.01
C20:0 Arachidic acid 0.07
C20:1 ω-11 Icosenoic acid 1.77
C20:1 ω-9 Eicosenoic acid 8.09
C20:2 ω-6 0.15
C20:4 ω-6 0.31
C20:3 0.09
C20:5 ω-3 Eicosapentaenoic acid 4.57
C22:0 Behenic acid 0.04
C22:1 ω-9 Erucic acid 0.69
C22:6 ω-3 Docosahexaenoic acid 6.06
C24:1 Nervonic acid 0.43
Others 15.83
74.51
12.02
1.51
%
C14:0 Myristic acid 2
C16:0 Palmitic acid 60 max
C18:0 Stearic acid 45 max
FATTY ACID
FATTY ACID
TOTAL
ω-3 total
ω-6 total
Table 2 - Amount of fatty acids [g/d] received
daily by cows of OM and OMAS group from 21
days before calving to the last day of pregnancy
Table 3 - Composition of the 74.5 g/d of fat
received daily by cows of CTR group from 21 days
before calving to the last day of pregnancy
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LO-PIRI IN-PIRI HI-PIRI Σ
CTR 1 4 3 8
OM 2 2 5 9
OMAS 6 2 1 8
Σ 9 8 9 26
Χ
2
 = 8.18 P < 0.10
LO-PIRI IN-PIRI HI-PIRI
Average PIRI score 9.15 20.48 28.49
STD 4.32 2.81 3.31
DIARRHEA LAMENESS RP METRITIS KETOSIS
CTR 1 1
OM 1 1
OMAS 2 2
DIARRHEA LAMENESS RP METRITIS KETOSIS
HI-PIRI
IN-PIRI 1
LO-PIRI 1 3 1 2
Table 4 - Distribution of cows per tertile of PIRI and group; average PIRI score per tertile
Table 5 - Count of clinical health problems found in each group of cows
Table 6 - Count of clinical health problems found in each tertile of PIRI
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GROUP N. OF COWS N. AI / PREGNANCY FSI INDEX
n. % n.
% of 
total 
cows
% of 
pregnant 
cows
mean sd
CTR 8 7 88 4 50 57 1.7 95.1 46.5 83.9
OM 9 8 89 3 33 38 2.3 120.3 47.0 44.5
OMAS 9 6 67 1 11 17 3.3 157.7 55.1 -4.7
TERTILE N. OF COWS N. AI / PREGNANCY FSI INDEX
n. % n.
% of 
total 
cows
% of 
pregnant 
cows
mean sd
HI-PIRI 9 7 78 3 33 43 2.0 101.3 45.9 65.1
IN-PIRI 8 8 100 4 50 50 2.3 122.8 59.1 49.4
LO-PIRI 9 6 67 1 11 17 3.0 147.2 49.8 6.2
PREGNANT PREGNANT AT 1
st
 AI DAYS OPEN
Table 7 - Fertility data divided for the three groups of treatment and calculation of FSI index
PREGNANT PREGNANT AT 1
st
 AI DAYS OPEN
Table 8 - Fertility data divided for the tertiles based on PIRI index and calculation of FSI index
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Figure 1 - Milk yield [kg/d] of dairy cows that received before calving a
supplement of palm oil (CTR group), ω-3 fatty acids alone (OM group) or in
combination with an i.m. injection of acetylsalicylic acid (OMAS group).
Figure 2 - Trend of body condition score [score] of dairy cows that received
before calving a supplement of palm oil (CTR group), ω-3 fatty acids alone (OM
group) or in combination with an i.m. injection of acetylsalicylic acid (OMAS
group).
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Figure 3 - Trend of rectal temperature [°C] of dairy cows that received before
calving a supplement of palm oil (CTR group), ω-3 fatty acids alone (OM group)
or in combination with an i.m. injection of acetylsalicylic acid (OMAS group).
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Figure 4 - Pattern of changes of glucose [mmol/L] in plasma collected in the
morning before feeding from periparturient dairy cows that received before
calving a supplement of palm oil (CTR group), ω-3 fatty acids alone (OM
group) or in combination with an i.m. injection of acetylsalicylic acid (ASA;
OMAS group). The average administration period for each group is showed
by the horizontal bars.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
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Figure 5 - Pattern of changes of cholesterol [mmol/L] in plasma collected in
the morning before feeding from periparturient dairy cows that received
before calving a supplement of palm oil (CTR group), ω-3 fatty acids alone
(OM group) or in combination with an i.m. injection of acetylsalicylic acid
(ASA; OMAS group). The average administration period for each group is
showed by the horizontal bars.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
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Figure 6 - Pattern of changes of albumin [g/L] in plasma collected in the
morning before feeding from periparturient dairy cows that received before
calving a supplement of palm oil (CTR group), ω-3 fatty acids alone (OM
group) or in combination with an i.m. injection of acetylsalicylic acid (ASA;
OMAS group). The average administration period for each group is showed
by the horizontal bars.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
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Figure 7 - Pattern of changes of GGT [U/L] in plasma collected in the
morning before feeding from periparturient dairy cows that received before
calving a supplement of palm oil (CTR group), ω-3 fatty acids alone (OM
group) or in combination with an i.m. injection of acetylsalicylic acid (ASA;
OMAS group). The average administration period for each group is showed
by the horizontal bars.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
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Figure 8 - Pattern of changes of bilirubin [mmol/L] in plasma collected in
the morning before feeding from periparturient dairy cows that received
before calving a supplement of palm oil (CTR group), ω-3 fatty acids alone
(OM group) or in combination with an i.m. injection of acetylsalicylic acid
(ASA; OMAS group). The average administration period for each group is
showed by the horizontal bars.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
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Figure 9 - Pattern of changes of ALP [U/L] in plasma collected in the
morning before feeding from periparturient dairy cows that received before
calving a supplement of palm oil (CTR group), ω-3 fatty acids alone (OM
group) or in combination with an i.m. injection of acetylsalicylic acid (ASA;
OMAS group). The average administration period for each group is showed
by the horizontal bars.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
DIM
35
45
55
65
-28 -21 -14 -7 0 7 14 21 28 35
days relative to calving 
CTR
OM
OMAS
ω-3 - OMAS 
ω-3 - OM 
ASA 
140
-28 -21 -14 -10 -7 -3 1 3 7 10 14 21 28 35
+
* ** * *
*
Figure 10 - Pattern of changes of haptoglobin [g/L] in plasma collected in
the morning before feeding from periparturient dairy cows that received
before calving a supplement of palm oil (CTR group), ω-3 fatty acids alone
(OM group) or in combination with an i.m. injection of acetylsalicylic acid
(ASA; OMAS group). The average administration period for each group is
showed by the horizontal bars.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
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Figure 11 - Pattern of changes of NEFA [mmol/L] in plasma collected in the
morning before feeding from periparturient dairy cows that received before
calving a supplement of palm oil (CTR group), ω-3 fatty acids alone (OM
group) or in combination with an i.m. injection of acetylsalicylic acid (ASA;
OMAS group). The average administration period for each group is showed
by the horizontal bars.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
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Figure 12 - Pattern of changes of β-hydroxybutyric acid [mmol/L] in plasma
collected in the morning before feeding from periparturient dairy cows that
received before calving a supplement of palm oil (CTR group), ω-3 fatty acids
alone (OM group) or in combination with an i.m. injection of acetylsalicylic
acid (ASA; OMAS group). The average administration period for each group
is showed by the horizontal bars.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
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Figure 13 - Pattern of changes of paraoxonase [U/mL] in plasma collected in
the morning before feeding from periparturient dairy cows that received
before calving a supplement of palm oil (CTR group), ω-3 fatty acids alone
(OM group) or in combination with an i.m. injection of acetylsalicylic acid
(ASA; OMAS group). The average administration period for each group is
showed by the horizontal bars.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
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Figure 14 - Pattern of changes of retinol [µg/100 mL] in plasma collected in
the morning before feeding from periparturient dairy cows that received
before calving a supplement of palm oil (CTR group), ω-3 fatty acids alone
(OM group) or in combination with an i.m. injection of acetylsalicylic acid
(ASA; OMAS group). The average administration period for each group is
showed by the horizontal bars.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
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Figure 15 - Pattern of changes of SDH [U/L] in plasma collected in the
morning before feeding from periparturient dairy cows that received before
calving a supplement of palm oil (CTR group), ω-3 fatty acids alone (OM
group) or in combination with an i.m. injection of acetylsalicylic acid (ASA;
OMAS group). The average administration period for each group is showed
by the horizontal bars.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
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Figure 19 - Pattern of changes of glucose [mmol/L] in plasma collected in the
morning before feeding from periparturient dairy cows divided in tertiles
according to their score of Post-calving Inflammatory Response Index (PIRI).
HI-PIRI = higher values; IN-PIRI = intermediate values; LO-PIRI = lower
values.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
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Figure 20 - Pattern of changes of cholesterol [mmol/L] in plasma collected in
the morning before feeding from periparturient dairy cows divided in tertiles
according to their score of Post-calving Inflammatory Response Index (PIRI).
HI-PIRI = higher values; IN-PIRI = intermediate values; LO-PIRI = lower
values.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
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Figure 21 - Pattern of changes of urea [mmol/L] in plasma collected in the
morning before feeding from periparturient dairy cows divided in tertiles
according to their score of Post-calving Inflammatory Response Index (PIRI).
HI-PIRI = higher values; IN-PIRI = intermediate values; LO-PIRI = lower
values.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
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Figure 22 - Pattern of changes of ceruloplasmin [µmol/L] in plasma collected
in the morning before feeding from periparturient dairy cows divided in tertiles
according to their score of Post-calving Inflammatory Response Index (PIRI).
HI-PIRI = higher values; IN-PIRI = intermediate values; LO-PIRI = lower
values.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
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Figure 23 - Pattern of changes of albumin [g/L] in plasma collected in the
morning before feeding from periparturient dairy cows divided in tertiles
according to their score of Post-calving Inflammatory Response Index (PIRI).
HI-PIRI = higher values; IN-PIRI = intermediate values; LO-PIRI = lower
values.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
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Figure 24 - Pattern of changes of GOT [U/L] in plasma collected in the
morning before feeding from periparturient dairy cows divided in tertiles
according to their score of Post-calving Inflammatory Response Index (PIRI).
HI-PIRI = higher values; IN-PIRI = intermediate values; LO-PIRI = lower
values.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
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Figure 25 - Pattern of changes of GGT [U/L] in plasma collected in the
morning before feeding from periparturient dairy cows divided in tertiles
according to their score of Post-calving Inflammatory Response Index (PIRI).
HI-PIRI = higher values; IN-PIRI = intermediate values; LO-PIRI = lower
values.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
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Figure 26 - Pattern of changes of bilirubin [mmol/L] in plasma collected in the
morning before feeding from periparturient dairy cows divided in tertiles
according to their score of Post-calving Inflammatory Response Index (PIRI).
HI-PIRI = higher values; IN-PIRI = intermediate values; LO-PIRI = lower
values.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
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Figure 27 - Pattern of changes of haptoglobin [g/L] in plasma collected in the
morning before feeding from periparturient dairy cows divided in tertiles
according to their score of Post-calving Inflammatory Response Index (PIRI).
HI-PIRI = higher values; IN-PIRI = intermediate values; LO-PIRI = lower
values.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
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Figure 28 - Pattern of changes of non-esterified fatty acids [mmol/L] in plasma
collected in the morning before feeding from periparturient dairy cows divided
in tertiles according to their score of Post-calving Inflammatory Response
Index (PIRI). HI-PIRI = higher values; IN-PIRI = intermediate values; LO-
PIRI = lower values.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
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Figure 29 - Pattern of changes of β-hydroxybutyric acid [mmol/L] in plasma
collected in the morning before feeding from periparturient dairy cows divided
in tertiles according to their score of Post-calving Inflammatory Response
Index (PIRI). HI-PIRI = higher values; IN-PIRI = intermediate values; LO-
PIRI = lower values.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
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Figure 30 - Pattern of changes of creatinine [mmol/L] in plasma collected in
the morning before feeding from periparturient dairy cows divided in tertiles
according to their score of Post-calving Inflammatory Response Index (PIRI).
HI-PIRI = higher values; IN-PIRI = intermediate values; LO-PIRI = lower
values.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
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Figure 31 - Pattern of changes of paraoxonase [U/mL] in plasma collected in
the morning before feeding from periparturient dairy cows divided in tertiles
according to their score of Post-calving Inflammatory Response Index (PIRI).
HI-PIRI = higher values; IN-PIRI = intermediate values; LO-PIRI = lower
values.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
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Figure 32 - Pattern of changes of retinol [µg/100 mL] in plasma collected in
the morning before feeding from periparturient dairy cows divided in tertiles
according to their score of Post-calving Inflammatory Response Index (PIRI).
HI-PIRI = higher values; IN-PIRI = intermediate values; LO-PIRI = lower
values.
Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
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Figure 16 - Milk yield [kg/d] of dairy cows divided in tertiles according to their score of Post-calving Inflammatory Response Index (PIRI). HI-PIRI =
higher values; IN-PIRI = intermediate values; LO-PIRI = lower values.
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Figure 17 - Trend of body condition score [points] of dairy cows divided in tertiles according to
their score of Post-calving Inflammatory Response Index (PIRI). HI-PIRI = higher values; IN-
PIRI = intermediate values; LO-PIRI = lower values.
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Statistically significant differences among groups.  + P<0.10; * P<0.05; ** P<0.01; *** P<0.001
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Figure 18 - Trend of somatic cell count [n/µL] of dairy cows divided in tertiles according to their score of Post-
calving Inflammatory Response Index (PIRI). HI-PIRI = higher values; IN-PIRI = intermediate values; LO-PIRI
= lower values.
0
100
200
300
7 14 21 28
days in milk 
HI-PIRI
IN-PIRI
LO-PIRI
163
Appendix 1 - Abbreviations
AIC Akaike’s Information Criterion LX Lipoxins
ALA α-linolenic acid MPO Myeloperoxidase
ALP Alkaline phosphatase NAPI Nutritional and Acute Phase Indicator
API Acute Phase Index NDF Neutral detergent fiber
+APP Positive acute phase protein NEFA Non-esterified fatty acids
-APP Negative acute phase protein NEL Net energy of lactation
APR Acute phase response NFkB Nuclear factor kB
ARA Arachidonic acid NSAID Non-steroidal anti-inflammatory drug
ASA Acetylsalicylic acid ORAC Oxygen radical absorbance capacity
BCS Body condition score PCA Principal component analysis
BHB β-hydroxybutyric acid PG Prostaglandin
BW Body weight PGHS Prostaglandin endoperoxide synthase
CLA Conjugated linoleic acid PINI Prognostic Inflammatory and Nutritional Index
COX Cyclooxigenase PIRI Post-calving Inflammatory Response Index
CP Crude protein PON Paraoxonase
DA Displacement of abomasum PPAR Peroxisome proliferator-activated receptor
DGLA Dihomo-γ-linoleic acid PUFA Polyunsaturated fatty acids
DHA Docosahexaenoic acid RBP Retinol binding protein
DIM Days in milk ROM Reactive oxygen metabolites
DMI Dry matter intake ROS Reactive oxygen species
EFOX Electrophilic oxo-derivatives RP Retained placenta
EPA Eicosapentaenoic acid Rv Resolvin
FA Fatty acid SCC Somatic cell count
FSI Fertility Status Index SD Standard deviation
GGT γ-glutamyl transpeptidase SDH Sorbitol dehydrogenase
GH Growth hormone SHp Thiol groups
GOT Glutamic oxaloacetic transaminase TG Triglycerides
HUFA Highly unsaturated fatty acids TGF Transforming growth factor
IFN Interferon TMR Total mixed ration
IL Interleukin TNF Tumor necrosis factor
LAI Liver Activity Index TX Thromboxane
LFI Liver Functionality Index VFA Volatile fatty acid
LOX Lypooxygenase VLDL Very-low density lipoprotein
LT Leukotrienes
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Reagent 1 (mL)
Diluent (H2O)  
(mL)
Reagent 2 (mL)
Diluent (H2O)  
(mL)
Glucose Endpoint 510 - 600 9 150 75
Cholesterol Endpoint 510 - 700 5 100 150
Urea Endpoint 340 8 270 30
Calcium Endpoint 570 - 660 9 180 0 180 0
Phosphorus Endpoint 340 - 375 6 150 20 150 20
Magnesium Rate 340 - 405 6 240 10 60 10
Na, K, Cl ISE device *
Zinc Endpoint 546 - 660 30 150 30
Ceruloplasmin Endpoint 546 - 660 25 140 40
Total protein Endpoint 546 - 700 6 200 0
Albumins Endpoint 600 - 700 5 230 0
AST/GOT Rate 340 14 70 75 35 0
GGT Rate 405 16 175 10
Bilirubin Endpoint 546 40 105 35 75 0
Alkaline phosphatase Rate 405 6 170 30
Haptoglobin Endpoint ** 450 12 60 5 170 5
NEFA Endpoint 546 - 660 4 140 40 70 20
BOHB Endpoint 340 7 280 10
Creatinine Endpoint 510 - 570 12 90 0 90 0
Paraoxonase Endpoint 405 8 125 125
Activated paraoxonase Endpoint 405 8 125 125
Reactive oxygen metabolites Rate 510 6 150 30
Thiol groups Endpoint 405-600 10 205 0
NO2 Endpoint 546 40 160 0
NOx Endpoint 546 40 160 0
Myeloperoxidase Rate 450 4 250 0
Sorbitol dehydrogenase Rate 340 18 215 0
Appendix 2 - ILAB600 photometric test parameters
** Final result of each samples is corrected by subtracting the corresponding sample blank
* The ILAB600 performs ISE measurements by an Indirect Method, since the samples are diluted before the measurement. The sample/diluent ratio is 1:21,7
Reagents
Test
Wavelength 
(nm)
Methodology
Sample 
volume (mL)
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